Stroke in young adults …

Stroke & Vascular Disorders

Updated 06.05.2024
Released 09.15.1994
Expires For CME 06.05.2027

Stroke in young adults

Authors: Julien Bogousslavsky MD, Jorge Moncayo-Gaete MD

See Contributor Disclosures

Editor: Steven R Levine MD

Stroke in young adults

In This Article

Quick Link

Introduction

Overview

Current epidemiological data suggest that strokes are occurring at a younger age. As many as one out of every six strokes occurs in a young adult (18 to 50 years old). Heterogeneity in incidence rates, stroke subtypes, and etiology among younger stroke victims in both developed and developing countries is often noted. Certain historical features and clinical manifestations may occasionally serve as clues toward specific stroke etiologies; nevertheless, determination of etiology, particularly of ischemic stroke in the young, poses many challenges due to a broad array of potential causes, both common and uncommon. In this article, the authors emphasize areas in which the differential diagnosis of stroke and etiologies (including those in pregnancy and puerperium) differs from that in older adults. The authors also note relevant information concerning prognosis of young adults with stroke.

Key points

	• Up to 15% of all cerebral infarcts occur in young adults (ages 18 to 50 years).
	• Etiologic diagnosis of stroke in young adults requires a different and more complex diagnostic work-up than that of stroke in older adults.
	• Overall, cardiac embolism and nonatherosclerotic vasculopathy are the main etiologies of cerebral infarct in younger patients.
	• Arteriovenous malformation and arterial hypertension are the main etiologies of cerebral hemorrhages.
	• Overall, and despite thorough investigation, the causes of up to one third of ischemias and hemorrhages remain undetermined.
	• Motor recovery is generally better than that of older patients, although a negative impact on multiple cognitive domains may be observed after a long-term follow up.

Historical note and terminology

Information regarding stroke in the younger patient population first began appearing in the literature in the 1950s and 1960s. Interest in this topic has increased due to escalating stroke rates in the younger age group and improvements in patient evaluation. A standardized definition of “young adults” is lacking. People under 40, 45, 50, or even 55 years of age have been classified as young adults. Currently, strokes occurring after adolescence and before the age of 50 are typically considered as occurring in young adults. Although several of the causes of stroke in the young are rare, they account in aggregate for many of the conditions leading to stroke (90; 110; 79). The incidence of stroke increases sharply after the age of 40, and the spectrum of etiology narrows, with atherosclerosis becoming increasingly common as the risk factors start resembling those in the elderly.

Clinical manifestations

Presentation and course

The symptoms and signs of stroke are directly related to the affected blood vessel (artery or vein), quantity of cerebral injury, and etiology; there is no apparent relationship to the specific age group affected. As such, a comprehensive history and physical examination (Table 1) are critical to detect the etiology of stroke (177; 90; 110; 79; 79).

Table 1. Selected Historical Information

May suggest a vascular cause:
	• Atherosclerosis
		- Tobacco use - Arterial hypertension - Hyperlipidemia - Diabetes mellitus - Prior radiation therapy - Homocystinuria
	• Dissection
		- Trauma - Chiropractic manipulation
May suggest a cardiac cause:
	• Intravenous drug abuse • Cardiac murmur • Splinter hemorrhages • Deep venous thrombosis • Association of stroke with exercise or straining • Valve replacement • Cancer
May suggest a hematologic cause:
	• Sickle cell disease • Deep venous thrombosis • Livedo reticularis • History of miscarriages or spontaneous abortions • Leukostasis • Asymmetric radial arterial pulses • Bone marrow transplantation
Other clues:
	• Recurrent headaches • Use of hormonal contraceptives • Papilledema • Alcohol use • Recent (within 1 week) febrile illness or systemic infection • Pregnancy or recent delivery • HIV infection • Family history of stroke, thrombosis, spontaneous abortion, or premature myocardial infarction • Hearing loss • History of uterine or bowel rupture or pneumothorax, suggesting a connective tissue disorder
	Adapted from (178)

Prognosis and complications

The prognosis and complications of stroke in young patients are highly dependent on the underlying cause of stroke, as well as the amount and location of CNS damage. The 30-day case fatality is low, particularly in ischemic stroke (0% to 6%), whereas it ranges from 20% to 36% for cerebral hemorrhage (71; 175; 66). The NOMASS data showed that 30-day case fatality rates were higher in blacks and Hispanics than in whites (71). Nedeltchev and colleagues found that higher admission NIH Stroke Scale scores, total anterior circulation stroke syndrome, and diabetes mellitus were independent predictors of unfavorable outcome; in their study, 68% achieved a modified Rankin score (mRS) of 0 to 1, 26% had a mRS score of 2 to 5, and 3% were dead by 3 months (129). In a large prospective cohort of 968 patients aged 15 to 49 years, outcome at 3 months after first-ever cerebral infarct was found to be favorable (mRS 0-1) in approximately half of the patients, and 80% were functionally independent (mRS 0-2) (145). Increasing age, stroke severity, and size of infarct were directly related to unfavorable outcome in this cohort. Moreover, high-density lipoprotein (HDL) levels were inversely correlated with adverse functional outcome (145).

In a French study of 287 young adult stroke patients by Leys and colleagues, the mortality rate was 4.5%, and the recurrence rate was 1.4% during the first year, dropping to 1.6% and 1% in the subsequent 2 years, respectively. Myocardial infarction occurred in 0.2% and seizures in 6.6% (97). Another study found a rate of recurrence of 7.4%, with nearly 90% having a moderate to excellent outcome (124). In the Iowa Stroke Registry, mortality was associated with age greater than 25 years and large-artery stroke etiology. In the Iowa study 7% of patients died from the initial stroke, 14% died over a follow-up period of 6 years, 9% had recurrent strokes, 0.4% had subsequent myocardial infarction, and only 49% of young stroke patients were still alive, were not disabled, were without recurrent vascular events, or had not undergone major vascular surgery by the end of the mean 6-year follow-up (77). In a Spanish study of 240 young adult stroke patients (191), 88% were alive after a mean follow-up of 12.3 years. The average mortality rate was 4.9% in the first year and 0.9% in subsequent years. Recurrent stroke occurred in 3.6% in the first year and 1.7% in subsequent years. Age greater than 35 years, male gender, carotid artery stenosis and the presence of cardiovascular risk factors was associated with worse outcome.

A 4.5% annual rate of symptomatic recurrent cerebral ischemic events (TIA or cerebral infarction) was found in 94 young patients with a follow-up of 48 months, most often in patients with an index cardioembolic infarct, followed by patients with an undetermined cause of infarct and a nonatherosclerotic vasculopathy. A neuroradiological (brain MRI) follow-up was performed 48 months after the index event in all 94 patients. Silent cerebral infarcts (lacunes) were documented in 9.5% of patients, mostly in patients with embolism from a cardiac source and undetermined cause of stroke (136).

In a cohort of 250 young patients with cerebral infarct with a mean follow-up period of 52 months, the estimated 10-year survival rate was 86% and the probability of composite vascular events (recurrent stroke, vascular death, and myocardial infarction) was 30.4%. Heart failure and initial stroke severity were the leading independent predictors of mortality. Men tended to have a lower survival rate and higher risk of composite vascular events than women (175).

The risk of recurrence of any vascular event was assessed in the short term (up to 6 months) and the long term (up to 5 years) in a prospective multicenter hospital-based cohort of 1216 patients aged 18 to 49 years with a neuroimaging-confirmed first ischemic stroke (192). The median age of these patients was 44 years, and 52% were male; the median follow-up was 4.6 years; stroke etiology was based on modified TOAST criteria, and cryptogenic stroke was found in nearly 25% of the cohort. The primary outcome was recurrence of any vascular event, which included fatal and nonfatal ischemic stroke, transient ischemic attack, myocardial infarction, and any arterial revascularization procedure. Recurrent vascular events occurred in 11% of patients; 55% of these events were ischemic strokes, and 30% were transient ischemic attacks, with a median interval before recurrence of 3.3 months. The cumulative 6-month incidence was 6.2% for recurrent stroke or transient ischemic attack and 6.7% for any vascular event (192). In the short term, the risk of any recurrent vascular event was significantly higher compared with cryptogenic stroke for patients with stroke due to cervical artery dissection, atherothrombotic stroke, and rare causes of stroke, with hazard ratios of 4.6, 3.5, and 3.2, respectively. The cumulative 5-year incidence was 10.1% for recurrent stroke or transient ischemic attack and 12.2% for any vascular event. Patients with atherothrombotic stroke (22.7%) had the highest risk, whereas patients with cryptogenic stroke (5.8%) had the lowest (192).

Aarnio and colleagues studied long-term mortality and stroke recurrence in first-ever ischemic stroke for patients aged 15 to 49 years adults (mean follow-up of 10.2 ± 4.3 years) (01). They found a 15.7% mortality rate (cumulative risk, 23.0%; 95% CI; 19.1-26.9) and a 13.6% recurrent stroke rate. The most important risk factor for mortality after first-ever ischemic stroke was recurrent stroke (hazard ratio, 16.68; 2.33-119.56). Observed mortality was 7-fold higher than the expected mortality (standardized mortality ratio, 6.94; 95% confidence interval, 5.84-8.04) and particularly high among patients who experienced a recurrent stroke (standardized mortality ratio, 14.43; 95% confidence interval, 10.11-18.74) (01).

Young adult patients with stroke remain at substantial risk of vascular recurrence in the long-term after an index event. After a mean follow-up of 9.1 years, one fifth of 724 consecutive patients with a first-ever transient ischemic attack, cerebral infarct, or intracerebral hemorrhage experienced at least one incident vascular event (stroke, myocardial infarction, or cardiac or peripheral arterial revascularization procedures) (159). The risk of any vascular recurrence was highest in the year following the index transient ischemic attack or cerebral infarct. In young adult patients with a cerebral infarct as index event, the 20-year cumulative stroke risk (19%) or any vascular event (33%) was higher compared with those patients with an initial transient ischemic attack or intracerebral hemorrhage. According to subgroups of TOAST criteria, the higher 20-year cumulative stroke recurrence risk was observed in patients with initial lacunar infarct (30%), whereas the atherothrombotic and cardioembolic stroke subgroups each had a 20-year cumulative stroke recurrence risk of 24%, and in patients with infarct of undetermined etiology the 20-year cumulative stroke recurrence risk was 12% (159).

Pezzini and associates followed 1867 patients with first-ever ischemic stroke (18 to 45 years of age) for a median of 40 months (139). They found 163 patients to have recurrent thrombotic events (average rate, 2.26 per 100 person-years at risk). The 10-year cumulative risk of these events was estimated at the level of 14.7% (95% CI; 12.2%-17.9%). The cumulative risk for brain ischemia was 14.0% (95%CI; 11.4%-17.1%) and 0.7% (95% CI; 0.4%-1.3%) for myocardial infarction or other arterial events. The independent predictors of recurrent thrombotic events were familial history of stroke, migraine with aura, circulating antiphospholipid antibodies, discontinuation of antiplatelet and antihypertensive medications, and any increase of one traditional vascular risk factor (139). Young adults with a previous transient ischemic attack have a 20-year cumulative risk of stroke of 17% and a 28% risk of any vascular event. Young adults with intracerebral hemorrhage exhibited the lowest risk of stroke recurrence (10%) and of any vascular event (11.6%) (159).

In a Swedish cohort of 17,149 patients aged 18 to 54 years who survived a first cerebral infarct from 1987 to 2006, patients were stratified into four 5-year periods according to their admission period (the reference period and the last period were 1987 to 1991 and 2002 to 2006, respectively) (60). In 14% of patients (2432), a recurrent cerebral infarct occurred within 4 years of follow-up. The cumulative 4-year risk of recurrence was higher in men than in women (with rates of 11.8% and 9.8%, respectively) during the 2002 to 2006 period. During the study period, the 4-year risk of recurrence decreased by 55% in men and by 59% in women. The highest risk of recurrence occurred within the first year after the index event and decreased thereafter, with an estimated annual recurrence rate of 2% from 2002 to 2006. Moreover, a decreasing trend in stroke recurrence over time was observed in all age groups except in patients aged 18 to 25 years.

In a prospective cohort study by Arntz and colleagues of 656 patients aged 18 to 50 years with a first lifetime ischemic stroke – out of whom 209 patients had a transient ischemic attack – and a mean follow-up of 12.4 years (21% of patients had a follow-up of more than 20 years), one third (197) of the patients had at least one more ischemic event (12). In this cohort, the 25-year cumulative risk for recurrent cerebral infarct was 30%, and for any ischemic event (transient ischemic attack or ischemic stroke), it was 45%. There were no differences in the 25-year cumulative risk of cerebral ischemia attributable to gender or to age category. Patients who had the first ischemic stroke due to cardioembolism or small-vessel disease had a higher 25-year cumulative risk than patients with “stroke of undetermined etiology” according to TOAST criteria, with rates of 50.8%, 37.5%, and 22.9%, respectively. Poor kidney function (eGFR < 60), smoking, history of peripheral arterial disease, and cardiac disease were independently associated with recurrent ischemic events (12). Moreover, in a cohort of 619 patients with ischemic stroke aged 18 to 50 years, 45% of patients had a poor functional outcome (modified Rankin scale ≥ 2), whereas 23% were still dependent in daily life (Instrumental Activities of Daily Living Scale < 8). Women had a 2- to 3-fold higher risk of poor functional outcome (183).

Data about mortality after intracerebral hemorrhage are scarce. An early mortality rate of 15% was observed in a retrospective series of 156 young patients (aged 18 to 45 years) with primary intracerebral hemorrhage (106). The mean age of the patients was 35 years old, and the mean intracerebral hemorrhage volume was 9.55 cc. Half of the hemorrhages were cortical, a third were located in the basal ganglia, and the remainder were infratentorial; 37% had intraventricular extension. A hemorrhage volume greater than 30 cc and a Glasgow Coma Scale lower than 5 were independently associated with a higher mortality risk. In a Finnish retrospective cohort, the mortality rate in 325 patients from the ages of 16 to 49 years with a first-ever nontraumatic intracerebral hemorrhage was 17% at 3 months. A higher 3-month mortality rate was associated with higher National Institutes of Health Stroke Scale scores, infratentorial hematoma location, and multiple hemorrhages. This observational study showed a lower mortality rate for patients undergoing surgical evacuation of hematoma than for those receiving conservative treatment (86).

Long-term mortality in individuals aged 18 to 49 years with a first-ever ischemic or hemorrhagic stroke was assessed using data from a Dutch population-based national stroke registry (54). In this study of 15,527 patients, the median age was 44 years, 55% had ischemic stroke, 20% had intracerebral hemorrhage, and the remainder had unspecified stroke. The mortality rate of any stroke at 30 days was 11.6% (1776 patients); it was 32% for patients with intracerebral hemorrhage and 7.4% for ischemic stroke patients. The primary endpoint was all causes of mortality, and median follow-up of patients who survived at least 30 days after stroke was 9.3 years. The annual risk of death in young patients with ischemic stroke was higher in the first year after stroke and tended to fall thereafter. Specifically, annual death risk at 1 year after stroke was 2.0% in men and 1.6% in women, whereas 10 years after ischemic stroke the rate was 1.4% in men and 0.9% in women (54). Compared with annual mortality in the general population, the excess mortality rate of young patients with ischemic stroke was 9.6 per 1000 person-years (the observed mortality rate was 12 whereas the expected mortality rate was 2.4). The excess mortality rate was higher in patients aged 40 to 49 years (11.0) than in the 30- to 39-year range (6.4). The main causes of death were stroke related (14%), cardiovascular disease (19%), and malignancy (29%) (54).

The annual risk of death in young patients with intracerebral hemorrhage decreased over time, ranging from 4.8% for men and 3.9% for women 1 year after index stroke to 1.9% for men and 1.4% for women 10 years after index stroke. Compared with mortality in the general population, an excess mortality rate of 16.5 per 1000 person-years was observed in young patients with hemorrhagic stroke (observed mortality was 18.7 and expected mortality was 2.2). The excess mortality rate was higher for patients aged 40 to 49 years (20.5) than for patients aged 30 to 39 years (18.6) and for those in the 20- to 29-year range (9.3). The main causes of death were cardiovascular disease (7%), stroke-related (22.6%), and malignancy (41.5%) (54).

The incidence of stroke in young adults is on the rise; still, outcome and prognosis are generally more favorable than in older patients. The impact of stroke is much higher in young adults with even minor residual deficits resulting in substantial loss of economic productivity and severe emotional or social sequelae that impair quality of life. In the Iowa study, only 42% of patients were able to resume work, and the majority reported emotional, social, or physical residuals that impacted quality of life (77). In the study by Leys and colleagues, favorable outcome (mRS 0-2) was observed in 94%; however, 4.2% lost their job despite achieving a mRS score of 0 to 1. The emotional, social, and physical problems affecting young stroke patients have also been emphasized by another study (128). Patients with strokes of unknown cause, however, do seem to have the lowest risk of stroke recurrence, with a relative risk of 0.1 compared to those with known cause (77).

A nearly 12-year follow-up of a retrospectively selected cohort of patients with brain infarction at a young age (mean age of 41 at index event) showed the worst prognosis compared with matched controls by sex and age. Thus, 77% of 187 young stroke patients had a 2-fold higher rate of depression, anxiety, and sleeping problems compared to a control population, whereas memory deficit was eight times higher in stroke patients as compared with controls. Also, young stroke patients were less able to handle full-time work compared with controls (197). Initiation of antidepressants within 1 year after a first-ever ischemic stroke was assessed, together with their associated factors, in 888 individuals aged between 15 and 49 years (29). In this cohort, 23% of patients were started on antidepressants, mostly selective serotonin reuptake inhibitors. The median time for starting antidepressant treatment was 102 days. The associated factors increasing antidepressant use were moderate strokes, limb paresis at discharge, silent infarcts, higher socioeconomic status, history of earlier antidepressant use, and current smoking. The main reason for starting antidepressants in most patients may have been post-stroke depression, although enhanced neuroplasticity may have been another reason for starting some patients on this medication.

Furthermore, in the last year, data of cognitive performance after a longer follow-up have been reported in a prospective cohort of 277 young patients with a mean age of 40 at index infarct (56% women, mostly with a good outcome according to the Barthel Index at follow-up) having a first-ever ischemic stroke, compared with a matched stroke-free population (146 controls) (162). The median follow-up was 11 years and almost half the patients had a follow-up of over 10 years. Compared with matched controls, up to 50% of young stroke patients exhibited below-average cognitive performance or impairment in processing speed, executive functioning, attention, working, and immediate and delayed memory. Regarding the location of index stroke, patients with supratentorial infarct on the left side had the worst cognitive outcome (162).

Long-term cognitive outcomes in young ischemic stroke patients (n = 96; median age at index event 43.0 years; 45.8% male) were studied by de Bruijn and colleagues (46). This study excluded patients with severe aphasia or preexistent cognitive impairment. Visual perception, visual and verbal memory, mental speed, and executive functioning were assessed and compared to controls with adjustment for education level. The authors found that the patients performed significantly worse than controls in mental speed tests (Stroop Color-Word Test Part 1 and Symbol-Digit Substitution Task), and verbal memory assessments (Word Pair test). These data confirm long-term cognitive impairment in this patient population (46).

Seizures within 7 days of ischemic stroke (acute symptomatic seizures) occurred in 3.5% of 995 young patients (ranging in age from 15 to 49 years) with a first-ever ischemic stroke included in a retrospective observational cohort (154). Nearly 60% of seizures occurred in the first 24 hours after stroke onset. Anxiolytic use, moderate stroke severity, cortical involvement, and hyponatremia at the time of index stroke were independently associated with a higher risk of acute symptomatic seizures. In addition, in the same cohort at 5 years after index infarct, 1 of 10 young ischemic stroke patients developed late poststroke seizures (7 days from brain infarct; patients with previous epilepsy were excluded). Total or partial anterior circulation infarct (Bamford criteria), history of acute symptomatic seizures, hemorrhagic infarction, antidepressant use at the time of late poststroke seizures, male gender, and hyperglycemia were independently associated with a higher risk for late poststroke seizures (154).

The risk of poststroke epilepsy (7 days after the initial event) was reported in another cohort of around 700 young adult stroke patients (mean age of 40.5, ranging from 18 to 50), 60% with cerebral infarct, 10% with intracerebral hemorrhage, and the remainder with a transient ischemic attack (11). In this series, 11% developed epilepsy after a mean follow-up of 9 years and 6% developed epilepsy with recurrent seizures, mainly within the first 12 months after the stroke. The first poststroke seizure was tonic-clonic generalized in one third of patients and simple partial in another third of patients. The highest risk of epilepsy was observed in patients with intracerebral hemorrhage (17%), followed by patients with cerebral infarct (14%), and the lowest risk was observed in patients with transient ischemic attack (3%). Cumulative risk of both poststroke epilepsy and epilepsy with recurrent seizures was higher in patients with intracerebral hemorrhage as compared to the other stroke subtypes. A high NIHSS score at admission was found to be a predictor of poststroke epilepsy and epilepsy with recurrent seizures (11).

Clinical vignette

Vignette 1. A 33-year-old man had acute onset of right-sided numbness and weakness with associated speech disturbance. He had been complaining of a pressure-type headache behind the left eye and neck discomfort for the past 10 days following a strenuous football practice. He was otherwise healthy with an unremarkable personal history. He did not use tobacco or illicit drugs and occasionally drank alcohol.

Neurologic examination revealed word-finding difficulties, left Horner syndrome, mild right central facial weakness, right hemiparesis, decreased sensation over the right hemibody, and an upgoing toe on the right.

Blood count, electrolytes, coagulation profile, and metabolic panel were within normal limits. Urine toxicology screen was negative. Initial cranial CT was negative. Echocardiogram was normal. MRI of the head showed an area of restricted diffusion in the left subcortical frontal lobe. MRA of the head was normal; MRA of the neck showed a cervical left internal carotid artery dissection extending 1.5 cm rostrally with significant luminal narrowing. He was anticoagulated with intravenous unfractionated heparin and was subsequently switched to warfarin therapy. A 3-month follow-up MRA showed recanalization of the left internal carotid artery. He was then switched to aspirin 325 mg daily. He remains asymptomatic.

Vignette 2. A 39-year-old woman with migraine without aura on oral contraceptives presented with a sudden-onset “worst headache of her life” with presyncopal episodes and right hemibody numbness and hemiparesis. She had two generalized tonic-clonic seizures on the date of admission and was loaded with intravenous valproic acid. Neurologic examination revealed right upper extremity pronator drift and mild right upper extremity weakness. Head CT without contrast demonstrated mild Sylvian fissure/temporo-occipital and left frontal convexity subarachnoid hemorrhage. There was hyperdensity in the superior sagittal sinus. CT angiography revealed absence of contrast enhancement in nearly the entire superior sagittal sinus, right transverse and sigmoid sinuses, and right internal jugular vein. No perfusion deficits were noted, although there was mild vasospasm of the M2 segment of the right MCA. Angiography demonstrated filling defects in the above vessels and in numerous bilateral paramedian frontoparietal cortical veins.

Subarachnoid hemorrhage in 39-year-old woman (image study)

(A, B) Head CT without contrast demonstrates right temporo-occipital and superior left frontal subarachnoid hemorrhage. The superior sagittal sinus is hyperdense. (C) Head CT angiography shows no enhancement of the right sigmoid s...

Lupus-sensitive activated partial thromboplastin time (aPTT) was mildly prolonged. There was no evidence of lupus anticoagulant or antiphospholipid antibody, however. Protein C & S levels, antithrombin, factor V Leiden mutation, activated protein C resistance, and prothrombin 20210A gene mutation were unremarkable. C-reactive protein was elevated (33.56 mg/L), and erythrocyte sedimentation rate was mildly elevated (21 mm/hr). Homocysteine was low (2.2 mcmol/L). Pregnancy screen and human immunodeficiency virus test were negative. Fasting lipids, complete blood count, antineuronal nuclear antibody, and rheumatoid factor were normal.

She was anticoagulated with heparin and started on Lovenox as a bridge to warfarin therapy. Mild right upper extremity pronator drift persisted at discharge. She was placed on levetiracetam and had no further seizures. A plan was made to repeat the lupus anticoagulant and antiphospholipid antibodies at 12 weeks.

Vignette 3. A right-handed, 16-year-old Hispanic woman living in a coastal rural community was admitted to the hospital 5 days after the sudden onset of an excruciating, throbbing left occipital headache, nausea, vomiting, and reduced level of consciousness. Five months before, she had been diagnosed with a molar pregnancy at 12 weeks of gestation, requiring dilatation and evacuation. She had no history of alcohol abuse, illicit drugs use, cranial trauma, or hematological disease; she was given no follow-up procedure after the early termination of this first pregnancy.

At hospital admission, her systemic examination was unremarkable. The neurologic examination showed an agitated and confused patient whose pupils were symmetric and responsive to light. Direct funduscopic examination was normal. No motor deficit was noted, and meningeal signs were present.

Coagulation screening was normal. Serum human chorionic gonadotropin levels were over 10,000 UI/ml. An initial noncontrast cranial CT showed a large left parietal hematoma involving the grey and white matter surrounded by a severe perilesional edema and ipsilateral intraventricular extension.

Parietal hematoma with surrounding edema, mass effect, and intraventricular extension (CT)

Noncontrast brain CT scan shows a large left parietal hematoma with surrounding edema, severe mass effect, and intraventricular extension. (Contributed by Dr. Jorge Moncayo-Gaete.)

Pelvic and pulmonary metastases were detected by pelvic ultrasonography and CT of the thorax, respectively.

Pulmonary nodule (CT)

Chest CT scan shows a solitary pulmonary nodule. (Contributed by Dr. Jorge Moncayo-Gaete.)

A brain MRI with and without contrast disclosed a large left parietal hematoma with intraventricular extension and severe perilesional edema. A small, ill-defined hyperintense lesion was also observed on the contralateral parietal lobe.

Hyperintense lesions in metastatic choriocarcinoma (brain MRI)

Brain MRI using FLAIR sequences shows a hyperintense lesion on the left parietal lobe and a hyperintense signal in the left lateral ventricle. A small, ill-defined hyperintense lesion can also be observed in the right parietal lob...

A diagnosis of intracranial bleeding due to metastatic choriocarcinoma was established, and the oncology department planned to start intravenous chemotherapy. Nevertheless, her condition deteriorated over the course of the next 3 days. A second noncontrast CT scan showed a large bilateral hematoma in both parietal lobes. She was progressively unresponsive and then died. An autopsy was not performed.

Occipital hematomas with perilesional edema (CT)

Second noncontrast CT scan 72 hours after admission shows large bilateral occipital hematomas with perilesional edema. (Contributed by Dr. Jorge Moncayo-Gaete.)

Biological basis

Etiology and pathogenesis

Stroke in the young usually results from a variety of conditions that, although individually uncommon, collectively account for approximately 40% of all strokes. Ischemic strokes can be caused by atherosclerotic cerebrovascular disease, nonatherosclerotic abnormalities, cardiac emboli, hematologic or coagulation disorders, substance abuse, migraines, oral contraceptive use, inflammatory disorders, and many other conditions. The spectrum of etiologies may differ by geographic region (59), with traditional stroke etiologies reportedly higher in eastern countries (150; 114). The etiology and risk factors of ischemic stroke after the age of 40 is similar to those seen in older patients (144). The frequency of etiologies of cerebral infarct in the young may differ according to the classification system used. Thus, based on the widely used TOAST classification system, the main etiologies in a series of 104 patients aged 18 to 45 were cardiac embolism (21%) and “other causes” (19%), whereas large atherothrombotic arteriopathy and small vessel disease each accounted for 10% of etiologies. In this cohort, the etiology of 40% of the cerebral infarcts could not be determined (37).

In a prospective cohort study on Caucasian patients aged 18 to 50 years with a first-ever stroke, 656 patients had ischemic stroke (31% transient ischemic attack); the mean age was 40.7 years, 79% were older than 35, and 47% were men. According to TOAST criteria, large-artery disease was significantly more common in patients over 35 years than in those below that age (11.6% vs. 2.9%, respectively). The rate of cardioembolic source was quite similar between the two age groups: 13.5% and 11.6% in those over and those under 35 years, respectively. Small-vessel disease was more common, although not significantly, in individuals over 35 years (11% vs. 6%). Ischemic stroke classified as “other defined etiology” was significantly more frequent in patients under 35 years (23%) than in the older patients (12%). The etiology of stroke remained undetermined in nearly half of the patients under 35 years and in one third of those over that threshold (190).

In a large cohort of 3331 patients between the ages of 15 and 50 with a first-ever cerebral infarct assessed according to TOAST criteria at 15 European stroke centers, stroke of other determined etiology was the most common subgroup (22%), followed by cardioembolism, found in 17% of the patients (204). In the subgroup of other determined etiology, cervical artery dissection (13%) was the main cause, followed by genetic thrombophilia and systemic vasculitis. In the cardioembolism subgroup, atrial fibrillation or flutter was the most common high-risk source of embolism, whereas patent foramen ovale was the most frequent low-risk source of embolism. Small-vessel occlusion and large-artery disease were found less frequently, accounting for 12% and 9% of etiologies, respectively. Etiology of ischemic stroke could not be determined in 40% of the patients (204). Compared by gender, the most common TOAST subgroup in females was “other determined etiology” (24%), mostly involving cervical artery dissection (13%) and nonatherosclerotic inflammatory arteriopathies (systemic vasculitis), whereas small-vessel occlusion (15%) and nonatherosclerotic, noninflammatory arteriopathies (mainly cervical artery dissection) were the most common TOAST etiological subgroups in males. The proportion of strokes of undetermined etiology was larger in females (43%) than in males (37%) (204).

In a cohort of 511 patients between 18 and 49 years of age (mean age of 39.8), most of whom were being seen for a first-ever stroke, no significant differences were found between females and males as to the proportion of small- and large-vessel disease, prothrombotic states, cervical arterial dissection, and stroke of undetermined etiology, although cardioembolism and substance abuse predominated in men as compared with women (127). Moreover, 44% of young stroke patients (and almost 60% of the women) had nontraditional etiologies for stroke, including prothrombotic states, migraine-related conditions, substance abuse, cervical artery dissection, cerebral venous thrombosis, inflammatory and miscellaneous vasculopathy, and pathological conditions occurring either exclusively (related to pregnancy and postpartum) or more frequently in women (fibromuscular dysplasia and Moyamoya syndrome) (127).

In a population-based study of a cohort of 950 patients aged 16 to 49 years, differences in ischemic stroke subtypes according to TOAST criteria were found between African Americans and European Americans (187). In young African-American patients, cardioembolic stroke (19%) and lacunar infarcts (18%) predominated over other etiologies, and one-half of the infarcts were considered to be cryptogenic. In European-American patients, cardioembolic stroke was the most common etiology (19%), followed by lacunar infarcts (13%); the etiology of infarct could not be determined in 52% of patients. Young African-American patients, particularly those over the age of 40, were found to be 1.6 times more likely to have an infarct due to small-vessel disease than similarly aged European-Americans when compared with all other subtypes combined. Patients over the age of 40 years were three times more likely to have either large-artery disease or lacunar infarct, whereas patients younger than 40 years of age had 1.6 times more risk of a cardioembolic infarct. Large-artery and small-vessel disease – with frequencies of 43% and 16%, respectively – were the most common etiologies in 1395 Chinese patients aged 18 to 50 years (mean age 38.5; 79% men). Cardioembolism accounted for 6% of all cerebral infarcts, and patent foramen ovale made up 59% of cardiac sources of embolism. One in 10 patients with cerebral infarct in this cohort had multiple potential causes of stroke, whereas the etiology was undetermined in 15% of patients (98).

In a secondary analysis of data from a prospective multicenter study in 15 European countries in the last few months, a comparison was done of the anterior- and posterior-circulation ischemic stroke etiologies, according to TOAST classification, in 2101 patients aged 18 to 50 years (195). One third (612) of these patients had a posterior circulation cerebral infarct (86% were unilateral and 50% were in the cerebellum). Large-artery disease (22%) and cardioembolism (18%) predominated in patients with anterior circulation stroke, whereas in patients with posterior circulation stroke these etiologies accounted for 15% each. Small penetrating artery disease was noticeably more common in posterior (15%) than in anterior (12%) circulation infarcts. Infarcts classified as “other determined etiology” were more common in patients with posterior circulation stroke (25%) than in those with anterior circulation stroke (16%). Cervical artery dissection was twice as common in patients with posterior circulation strokes (17%) as in those with anterior circulation strokes (8%). Patent foramen ovale was more common in posterior circulation stroke (31%) than in anterior circulation stroke (25%). In both arterial territories, the cause of one third of strokes remained undetermined (195).

Small vessel disease was the most common etiology in a prospective multicenter study that enrolled 519 Japanese patients aged 16 to 55 years (median age 48, 27% female) with ischemic stroke (89). Hypertension, dyslipidemia, and current smoking were the most common risk factors. Heavy alcohol consumption, tobacco use, and high body mass index were significantly higher in men than in women, whereas migraine was significantly more prevalent in women than in men. Based on TOAST criteria, small vessel disease accounted for 28% of etiologies, and the frequency was similar in the young group (≤ 44 years), middle age group (45 to 50 years), and over middle age group (≥ 51 years). One in six infarcts were attributed to large artery disease, with a frequency significantly higher in the over middle age group than in the young group. Stroke was caused by cardioembolism in 8% of patients, and the most common source of cardioembolism was atrial fibrillation. One in five ischemic strokes was due to another determined cause, the most common being cervical artery dissection (70%). Intracranial cervical artery dissection was more frequent than extracranial artery dissection. Another determined cause was more prevalent in the young group than in the over middle age group. The etiology of stroke could not be determined in 16% of patients, and 11% of patients were considered to have an embolic stroke of undetermined source.

A retrospective study of 322 patients (the current group) aged 15 to 45 years admitted to a comprehensive stroke center with ischemic stroke between 2010 and 2016 compared with 329 patients (the historical group) with the same diagnosis and similar age range treated at the same center between 1977 and 1993 found that stroke etiologies may change over time (167). Compared to the historical group, young patients in the current group had more vessel imaging studies (computed tomography angiography, magnetic resonance angiography, digital subtraction angiography, and carotid duplex) as well as transesophageal and lower transthoracic echocardiography studies. Magnetic resonance angiography and computed tomography angiography neuroimaging studies were not available at the time of the historical group. Based on TOAST criteria, about 10% of ischemic strokes in both groups were due to large artery disease. Cardioembolic etiology in the historical group (17.6%) was slightly more frequent than in the current group (14%). Small vessel disease in the current group (4%) was significantly lower compared to the historical group (7.9%). Cryptogenic stroke was the most common subtype in both groups: 34.5% and 37% in the current and historical groups, respectively. Cervical artery dissection in the current group (24.5%) was significantly more frequent than in the historical group (6%).

On the other hand, using the ASCO system, which introduces a complete stroke phenotype classification (stroke etiology and the presence of all underlying diseases, divided by grade of severity), the proportion of small vessel disease in the same cohort was no different in comparison to the TOAST system, whereas the frequencies of large vessel disease, embolism from a cardiac source, and other etiologies were lower compared to the TOAST criteria, with 8.7%, 10.6%, and 13.5%, respectively. The rate of stroke of undetermined cause (“cryptogenic strokes”) using the corresponding score in the ASCO system (A0S0C0O0) was half that of the TOAST system (19%) (37). Jaffre and coworkers identified a definite cause of stroke based on the ASCO classification system (grade 1) in half of 400 patients aged 16 to 54 (mean age 44.5; 39% under 44) with a first cerebral infarct. Atherosclerosis and other definite causes (mainly carotid and vertebral arterial dissections) accounted for 18% and 16% of cases, respectively; cardioembolism (9%) and small vessel disease (7%) were less common etiologies (72).

Liu and coworkers used the ASCOD classification system to define the ischemic stroke phenotypes and their possible causality level in a retrospective study cohort of 157 patients aged 18 to 50 years admitted to an urban tertiary care center (100). Mean patient age was 43.4 years, the mean NIHSS score was 5.5 points, and 16 patients (10%) had a recurrent ischemic stroke. Of all possibly causal phenotypes (those receiving a score of 1 or 2), cardiac disease was the most commonly identified etiology (25.7%), followed by small vessel disease (22%) and atherosclerosis (21%), whereas arterial dissection (1.7%) was the least common of the possible causal phenotypes (100).

Frequency of cryptogenic ischemic stroke may vary according to the classification system used, as recently demonstrated in a Dutch prospective multicenter stroke study comprising 1322 individuals aged 18 to 49 years with a first-ever symptomatic ischemic stroke (53). The cohort mean age was 44.2 years, 66% were over 40, and 52% were men. Based on TOAST criteria, 21% and 17% of infarcts were due to other determined cause and cardiac embolic source, respectively. A quarter of the patients had a cryptogenic stroke (19.7% when ASCOD classification was applied). However, when a pediatric classification system (the International Pediatric Stroke Study definitions) was used and risk factors were assigned into one of the 10 predetermined categories, 0.8% of the 1322 young individuals were found to have no risk factors and were categorized as cryptogenic stroke (53).

Hemorrhagic strokes may be caused by underlying vascular structural abnormalities, abnormal composition of blood vessels, effects of chronic arterial hypertension, trauma, or effects of acute hypertension and vasoconstriction, such as in the setting of sympathomimetic or illicit drug use. The cause of up to one third of hemorrhages may remain unknown even after an exhaustive evaluation, especially in those aged 40 to 49 years (14; 92; 87). A notable genetic study found that polymorphisms in the glutathione peroxidase (Gpx-3) gene, perhaps via interactions with conventional vascular risk factors, increase the risk for ischemic stroke in children and young adults (194). Such polymorphisms affect the gene's transcriptional activity and thereby compromise plasma antioxidant and antithrombotic activities. Arterial hypertension and arteriovenous malformations were the leading causes in 69 patients with a first-ever intracerebral hemorrhage included in a prospective study aimed at assessing the consequences of stroke in the young. Etiology could not be determined in nearly 20% of these patients and 18% had an incomplete evaluation, mainly because of early death (159). In one study, arterial hypertension and vascular malformations (mainly cavernous angiomas) were found to be the leading etiologies – each accounting for 25% of cases – in a large retrospective cohort of nontraumatic intracerebral hemorrhage. Cerebral vein thrombosis and illicit drug use were the most common etiologies in patients younger than 30, whereas structural lesions (arteriovenous malformations and cavernous angiomas) and hypertensive microangiopathy were the main etiologies in the over-30 group. In a retrospective study of 1,706 patients with acute intracerebral hemorrhage, 42 (2.5%) had cavernous malformations (confirmed by pathological examination), and 10 (0.6%) had a developmental venous anomaly (stellate or linear vascular lesions converging into a collecting vein with a caput medusae-like appearance after enhancement on brain MRI). The mean age of the 42 patients with cavernous malformations was 37 years, and the mean hematoma size was two centimeters; 48% of hemorrhages (20) were located in the brainstem, mainly in the pons, and one third were located in the cortex. In the 10 patients with developmental venous anomalies, the mean age was 31 years; six hematomas were located in the cerebellum, two in the brainstem, and the remainder were supratentorial with a mean hematoma size of 1.8 centimeters (99).

In a small retrospective cohort study of 63 patients 18 to 45 years of age (mean aged 35.4 years) with spontaneous intracerebral hemorrhage, the predominant hemorrhage etiologies according to SMASH-U classification were arterial hypertension (37%) and vascular malformations (29%). Hemorrhage was due to illicit drugs in 6% of patients, and etiology remained undetermined in 17%. The most frequent hemorrhage locations were deep (46%), followed by brainstem and cerebellar (25%), lobar (22%), and primary intraventricular (6%); 57% of patients had an ICH score of 0 to 1 and 14% had a score of 4 to 5 (28).

Some degree of hypertension was found in 91 (82.7%) out of 110 patients aged 18 to 50 years who had spontaneous intracerebral hemorrhage at a median age of 45, but hypertension was considered the definitive etiology according to H-ATOMIC criteria in 44% of the hypertensive patients (58). Vascular malformations, tumors, and anticoagulation were uncommon (5.5%) causes, and etiology remained cryptogenic in only 3.6% of cases. Interestingly, over half of the patients had multiple potential etiologies, and no etiology could thus be definitively assigned (58).

In a retrospective Asiatic cohort of 259 young individuals (mean aged 36.4 years) with nontraumatic intracerebral hemorrhage, the most common causes were arterial hypertension (43%), followed by vascular malformations (arteriovenous malformation and cavernoma); however, etiology could not be determined in approximately 20% of the patients (38).

Coronavirus disease 2019 (COVID-2019), caused by the novel SARS-coronavirus-2 (SARS-CoV-2), emerged in China in late 2019 and paralyzed the world in record time, being declared a pandemic by the World Health Organization in March 2020. Based on a real-world observational database from TriNetX, a global health research network, the incidence of acute ischemic stroke was 0.7% among 9358 individuals under 50 years of age with laboratory-confirmed COVID-19 infection (07). A third of all patients in this dataset had a severe case of COVID-19. Compared with COVID-19-infected patients who had no cerebral infarct, those with COVID-19 infection plus ischemic stroke were significantly older and had significantly more other underlying disorders, including hypertension, type 2 diabetes mellitus, heart failure, obesity, renal insufficiency, previous stroke, and nicotine dependence. Patients with stroke had a 15% mortality rate, whereas the mortality rate in no-stroke patients was 0.6%.

Oxley and colleagues reported five patients with laboratory-proven COVID-19 infection who presented an acute cerebral infarct due to large vessel occlusion (135). Two of these patients had respiratory symptoms: one presented with disorder of consciousness, and the other two reported no respiratory or systemic symptoms. On admission, the mean NIHSS score was 17 and mean age was 40.4 years. Three patients had previously had diabetes, hypertension, or hyperlipidemia, and one had had a mild stroke. Endovascular therapy (clot retrieval) was performed in three patients, intravenous thrombolysis was administered in 1, and oral anticoagulation was prescribed to the remaining patient (135).

Cerebral venous thrombosis has also been reported in patients with laboratory-proven COVID-19 infection. Three previously healthy young adults (ages ranging from 23 to 41 years) each developed a fatal cerebral venous thrombosis after a median of 7 days from the onset of COVID-19 infection (34). Dehydration was a precipitating factor in two patients, and one patient used contraceptive pills. Two patients presented hemorrhagic venous infarcts on neuroimaging. On CT venogram, the first patient showed thrombosis in the superficial and deep venous system, whereas the second exhibited occlusion of the great cerebral vein, the internal cerebral vein, and the straight sinus; the remaining patient had thrombosis in the deep medullary veins (34).

Hemorrhagic stroke in young people infected with COVID-19 seems to be less common than ischemic stroke. Four patients (mean aged 49.25 years, range 41 to 54 years, one female), all with arterial hypertension, two with type 2 diabetes mellitus, one with hyperlipidemia, and one with recurrent episodes of deep venous thrombosis, underwent warfarin anticoagulation (international normalized ratio: 3.2). Three patients developed a single frontal lobar hemorrhage, and the other patient had multiple hemorrhages in both frontal lobes. None of the patients showed any abnormality on CT angiography. The average time between onset of COVID-19 symptoms and diagnosis of intracerebral hemorrhage was about 30 days. All these patients had a modified Rankin score ranging between 4 and 5 (16).

The exact mechanisms underlying stroke in the setting of COVID-19 infection are not presently known. Nevertheless, several putative mechanisms acting alone or, more likely, in various combinations may be key contributors in stroke pathophysiology. Direct or indirect endothelial injury induced by SARS-CoV-2 and brain renin-angiotensin system dysfunction are the proposed mechanisms associated with COVID-19 infection and stroke. An inflammatory state in the setting of COVID-19 infection induces a hypercoagulable milieu leading to arterial and venous thrombosis. Stroke patients with COVID-19 infection had more cardiovascular risk factors compared to patients without stroke. Rupture or erosion of atherosclerotic plaque or destabilization of previously asymptomatic cardiovascular conditions induced by the systemic inflammatory state or myocardial injury induced by SARS-coronavirus may contribute to cerebrovascular disease. In addition, the inflammatory state and concomitant cytokine storm may lead to potentially compromised blood-brain barrier integrity (15; 50).

Epidemiology

Worldwide, incidence of stroke in infants and young children is reported to be from 3 to 13 cases per 100,000, with a recurrence rate of 6% to 40% (62; 179; 152). Annual stroke incidence in individuals aged 15 to 45 varies greatly, depending on how estimates are derived, but appears to range from 5.83 to 12.1 cases per 100,000 persons (90; 108; 66). Epidemiological data from the 2019 Global Burden of Disease (GBD) database (epidemiological data from 204 countries and 21 GBD regions) estimated that the global age-standardized incidence rate of ischemic stroke in young adults (15 to 49 years) was 21.84 per 100,000 population (208). The age-standardized rate of ischemic stroke was higher in men and in regions with a low socio-demographic index. The regions with the highest age-standardized incidence rates were North Africa, the Middle East, Eastern Europe, and the Caribbean, whereas those with the lowest age-standardized incidence rates were Western Europe, Australasia, and southern Latin America (208).

In developed Western countries, up to 13% of first-ever ischemic strokes occur in people younger than 45 years of age (23; 21; 129; 149), whereas this age group may account for 20% to 30% of first-time strokes in developing countries (147; 05). The incidence of ischemic stroke ranges from 4/100,000 to 47/100,000 in those 25 to 34 years of age, and from 9/100,000 to 93/100,000 in those 35 to 44 years of age in the European population (188). In the United States, the ethnic composition of the population may produce differences in reported stroke incidence among young individuals; the Baltimore-Washington Cooperative Young Stroke Study reported an annual cerebral infarction incidence of 10.55 per 100,000 Caucasians and 21.7 per 100,000 African Americans (80). In a retrospective cohort study from 2001 to 2014 that included 10% of a random sample from a U.S. health insurance database, 5198 individuals under the age of 55 years had an ischemic stroke (96). In this database, ischemic stroke occurred more frequently in women than in men in those aged 25 to 44 years. The rate of ischemic stroke in individuals aged 25 to 34 years was 16.9 per 100,000 in women and 11.9 per 100,000 in men. In individuals aged 35 to 44 years, the rate was 39.9 per 100,000 in women and 34.9 per 100,000 in men. A metaanalysis of six population-based studies analyzed stroke incidence in 4,101,084 individuals in the Latin American and Caribbean region (134). In this metaanalysis, individuals under the age of 45 years, particularly women, were found to have a higher relative temporal trend ratio of first ischemic stroke during the 2010 to 2019 period compared to the 2000 to 2009 period (134).

For intracerebral hemorrhage, the rate for whites was 3 per 100,000 and for African Americans was 9 per 100,000 (subarachnoid hemorrhage 60% and intracerebral hemorrhage 40%). The population-based Northern Manhattan Stroke Project study found incidence rates for stroke in the young of 23 per 100,000 persons (10 for infarct, seven for intracerebral hemorrhage, and six for subarachnoid hemorrhage). The risk was more than 2-fold higher for blacks and Hispanics as compared with whites (71). These urban and suburban North American population studies, however, found incidences somewhat higher than other studies. To put this entity into perspective, stroke in this age group is reportedly twice as prevalent as multiple sclerosis in 18- to 44-year-old persons (42). Although the overall male: female ratio is equal between the ages of 15 and 45 years, females predominate if the age is restricted to below 30 years (149; 175). This correlates with childbearing years when the risk is predominantly for hemorrhagic stroke. Based on a retrospective cohort of 336 patients aged 16 to 49 years (median age of 42) with a first-ever nontraumatic intracerebral hemorrhage, an annual incidence in the young was estimated at 4.9 per 100.00, with higher rates in males (6.2) than in females (4.0) (87).

Prevention

Stroke prevention is of paramount importance in young individuals because of its high impact on productivity and future quality of life. Unfortunately, no single preventative measure can reduce the general risk of stroke in young adults. As many risks are modifiable, general prevention strategies (as in the older population) may lessen the impact of stroke in this population. A risk factor study found diabetes (odds ratio 11.6), hypertension (odds ratio 6.8), heart disease (odds ratio 2.7), current tobacco use (odds ratio 2.5), and long history of alcohol use (odds ratio 15.3) to be risk factors in patients aged 15 to 45 years with first onset stroke (207). Neither heavy alcohol use just prior to stroke or history of oral contraceptive use was associated with an increased risk of stroke in this study. Tobacco use, elevated triglycerides, and alcohol abuse were more common in men whereas migraine was more frequent in women. Arterial hypertension and elevated cholesterol and triglycerides are more common in patients older than 35 years. In patients below 35 years, oral contraceptive use is more prevalent (32). Tobacco use and arterial hypertension were especially noted in young African-American patients (153). The amount and type of alcohol can influence stroke risk, with light to moderate alcohol consumption reducing stroke risk in young women (105). Heavy alcohol consumption was found to be associated with a higher risk of stroke in 1,536,668 Koreans aged 20 to 39 years (39). Data from a nationwide population-based cohort study estimated the amount of alcohol consumption in four consecutive annual health examinations in these young individuals (mean aged 29.5 years, 71.5% men) and a cumulative alcohol burden score was defined as the sum of all points for alcohol consumption during these four health examinations. Compared with nondrinkers, young individuals who consumed more than 105 g of alcohol per week (a moderate to heavy consumption pattern) had at least a 30% higher risk of hemorrhagic stroke (39).

A population-based case-control study of early-onset ischemic stroke found that stroke risk rises with the number of risk factors (115). Hypertension, diabetes mellitus, obesity (a body mass index of 30 or greater), and current smoking were assessed in 1034 young adults with stroke (mean aged 41 years) and 1091 non-stroke controls (mean aged 38.6 years). Stroke risk increased exponentially for white patients and Afro-American patients according to the number of risk factors. Three of four stroke risk factors were found in 26% of ischemic stroke patients aged 35 to 49 years and in 1.9% of those aged 5 to 34 years. Compared to their white counterparts, young Afro-American stroke patients were six-fold more likely to present all four stroke risk factors (115).

In general, reduction of modifiable risk factors is the single best preventative action to lessen strokes in both younger and older individuals (130). Primary stroke prevention guidelines recommend regular screening and appropriate treatment of hypertension and diabetes, smoking cessation for all current smokers, weight reduction in overweight persons, a healthy diet, and regular exercise (116; 10; 48). No similar recommendations have been specifically directed at the younger stroke patient population (116; 10). It is recommended that female sufferers of migraine, particularly with aura, stop smoking and replace hormonal contraception (especially those containing estrogen) with other methods. Attempting to reduce migraine frequency through treatment, particularly in the case of the aural type, may be a reasonable step, although there is no evidence that this will reduce stroke occurrence (116; 10). Patients with a history of stroke related to drug abuse (cocaine and amphetamines) should be referred to an appropriate therapeutic program. Treatment of Fabry disease with enzyme replacement therapy has not proven to reduce stroke risk (116).

In a retrospective Norwegian study, the risk of recurrent stroke or myocardial infarction was proportional to the number of risk factors, being as high as 30% with four risk factors and 67% with five risk factors, and as low as 2.1% in patients with no risk factors (126). The authors suggest that long-term stroke preventive measures may not be warranted in young stroke patients with no identifiable risk factors. Risk factor control can be challenging in the young population: in the French PFO-ASA study, greater than 50% to 60% of young stroke patients continued smoking or had poorly controlled blood pressure after their stroke (13). Prevention has a major role in a few diseases that predispose to stroke in the young: for example, timely blood transfusions have been shown to reduce the risk for stroke in patients with sickle cell disease (04). It was also shown that periodic red cell transfusion (target reduction of hemoglobin S to less than 30%) has been shown to effectively reduce the risk for stroke in patients with sickle cell disease (116). A history of illicit and licit (including over-the-counter) drug use should be sought during patient encounters and appropriate counseling initiated as needed. Caution has also been recommended in women using oral contraceptives with additional risk factors (cigarette smoking or prior thromboembolic events) in the setting of migraine (24).

As has been stated previously, the burden of stroke is increasing among the young worldwide. In a comprehensive review of stroke in young adults and adolescents, Singhal and colleagues emphasized the need to implement educational, preventive, and support strategies, particularly in high-risk groups and young stroke survivors and their families (172). They also highlighted the need to promote research on the topic of stroke in young adults to gather reliable epidemiological data and provide feedback for planning and service delivery by stroke professionals and policymakers (172).

Investment in research and educational campaigns on this topic may be insufficient or negligible in countries with middle- and, particularly, low-income economies where other health problems are considered priorities. Nevertheless, these countries can benefit from successful educational strategies, stroke survivor support experiences, and prevention and rehabilitation interventions targeted at young adults with stroke that have been developed in high-income economies but are adaptable to local facilities.

The benefit of endovascular therapy for prevention of stroke recurrence in patients with patent foramen ovale was assessed by a meta-analysis comprising five large randomized controlled trials published between 2012 and 2017 (132). The trials were all composed of patent foramen ovale patients aged 16 to 60 who had had an ischemic stroke in the previous 9 months (two trials also enrolled patients with a transient ischemic attack) and who had no other identifiable cause of stroke. Out of a total of 3440 patients (mean age 44.9 years), 1829 were randomly allocated to patent device closure and further dual antiplatelet therapy for at least 1 month followed by a single antiplatelet agent, whereas the remaining 1611 patients received standard medical care alone (anticoagulation or mono or dual antiplatelet therapy, at the discretion of the treating physician). Patent foramen ovale diagnosis was established by transesophageal echocardiography with bubble study. Concomitant atrial septal defect was present in one third of all patients (132). The Amplatzer device was used in two trials, the Gore septal occluder in one trial, and the Startflex device in another trial (this last device is no longer available), whereas multiple devices were employed in the remaining trial.

After a mean follow-up of 4 years, patent foramen ovale transcatheter device closure significantly reduced the risk of recurrent ischemic stroke (fatal and nonfatal cerebral infarct and transient ischemic attack) by 46% compared with medical therapy alone (132). The benefit in reducing stroke recurrence was significantly higher in male patients (relative risk 0.45) compared to female patients (relative risk 0.73). In addition, the effect of patent foramen ovale closure on stroke recurrence was significantly higher in patients under the age of 45 (relative risk 0.42) than in patients over 45 (relative risk 0.54). Patients with large shunts seem to benefit more from patent foramen ovale closure; the relative risk reduction was 0.86 compared to patients with medium-size shunts (relative risk 0.26).

Neither the presence nor the absence of atrial septal aneurysm had any effect on stroke recurrence rate in the patient groups, but there was a 4.5-fold higher risk of new-onset atrial fibrillation – occurring in the periprocedural period or within 45 days after the procedure – in patients who underwent patent foramen ovale closure compared with patients treated medically. Moreover, 75% of atrial fibrillation episodes were paroxysmal and transient. No differences in bleeding complications occurred between the groups (132).

The latest recommendations of the American Academy of Neurology state that a definite causality between patent foramen ovale as the source of brain embolism and ischemic stroke should be established in individuals younger than 60 years before considering a percutaneous patent foramen ovale closure procedure. The benefit of reducing absolute risk of ischemic stroke recurrence through percutaneous patent foramen ovale closure should outweigh the risk of periprocedural complications and the annual rate of nonperiprocedural atrial fibrillation risk. Patients undergoing medical treatment for ischemic stroke caused by patent foramen ovale may receive antiplatelet monotherapy or anticoagulation (vitamin K antagonists or direct oral anticoagulants) (117).

The updated secondary stroke prevention guidelines from the American Heart Association recommend closing patent foramen ovale percutaneously in patients aged 18 to 60 years with a nonlacunar ischemic stroke and who have patent foramen ovale with high-risk anatomical signs of embolism and no other identified cause of stroke after a thoroughly etiological investigation (83). Long-term antiplatelet therapy should be maintained after percutaneous patent foramen ovale closure. The benefit of percutaneous patent foramen ovale closure coupled with long-term antiplatelet therapy has still not been established for patients with ischemic stroke and patent foramen ovale considered a low embolism risk based on anatomical features.

Differential diagnosis

Confusing conditions

Conditions that can simulate stroke include focal seizures, migraine with prolonged aura, and migraine variants such as basilar and hemiplegic migraines, acute vestibular syndrome, hypo- and hyperglycemia, periodic paralysis, multiple sclerosis, brain tumor, subdural hematoma, cerebral contusion, encephalitis, radiculopathy, neuromuscular junction disorders, neuropathy, Wernicke encephalopathy, and conversion disorder (172). A detailed history, physical exam, and appropriate laboratory or neuroimaging tests should be performed to further evaluate for these stroke mimics.

Associated or underlying disorders

Defining the cause of stroke in a 15- to 45-year-old patient is often challenging because of the broad spectrum of etiologies to be considered. Published studies of ischemic stroke in the young attribute variable percentages to several stroke etiologies. An overview suggests that the cause of stroke is large artery atherosclerosis in 0% to 63% of patients, nonatherosclerotic disease in 3% to 33%, small vessel disease in 2% to 21%, cardiac embolism in 5% to 37%, hematologic disease in 3% to 28%, oral contraceptives in 3% to 24%, drug abuse in 2% to 11%, and migraine in 2% to 18% of patients. In 4% to 56% of patients, the etiology remains undefined. Significant variability in the proportion of strokes attributed to any one cause is related to the population used to collect the data (community-based vs. tertiary care center) as well as the extent and availability of diagnostic evaluation. Multiple stroke etiologies may coexist.

A report including cases from both community and referral hospitals determined etiology percentages from Baltimore City and regional counties: cardiac 15.4%, small vessel disease 9.8%, hematologic 8.9%, nonatherosclerotic vasculopathy 5.6%, substance abuse 4.7%, oral contraceptive use 2.6%, large artery atherosclerosis 1.9%, migraine 0.7%, and cryptogenic 31.8% (79). Transesophageal echocardiography was not readily available, possibly accounting for the relatively high percentage of strokes without a definable cause. A Swedish population-based epidemiological survey of stroke in the young found the following frequencies of etiologies: cardiac 33%, nonatherosclerotic vasculopathy 19%, atherosclerotic 11%, hematologic 7%, oral contraceptive use 3%, migraine 1%, and cryptogenic 21%. Transesophageal echocardiography was more available in this study (90). Cardioembolism, mainly from patent foramen ovale and cardiomyopathy, accounted for approximately half of cerebral infarcts in 215 patients 18 to 45 years of age who were evaluated in a tertiary stroke center. One third of the patients had “other determined causes,” according to TOAST criteria, mainly comprising arterial dissection (13%), reversible cerebral vasoconstriction syndromes (5%), moyamoya disease (3%), and hypercoagulable state (2.8%). Atherosclerotic small-vessel and large-vessel disease were found in 7% and 2% of the patients, respectively, and occurred exclusively in patients older than 36 years of age. Probably because of extensive diagnostic workup, the cause remained undetermined in only 9% of the patients in this cohort (75).

Atherosclerosis occurs in patients with predisposing risk factors and increases in a linear fashion with advancing age (7% to 30% incidence in patients younger than 50 years). Atherosclerosis as a cause of stroke is less prominent from the 15- to 30-year age group (2%) and more prominent in the 30- to 45-year age group (30% to 35%) (22; 32).

Physicians should avoid attributing atherosclerosis as the etiology of stroke in young patients simply because risk factors are present; nevertheless, with the growing prevalence of obesity, diabetes, and metabolic syndrome, atherosclerosis is increasingly being recognized as the cause of stroke in children and young adults. In fact, large artery atherosclerosis (mostly diagnosed by angiography and ultrasound examination) was the most common cause of stroke in 197 Chinese young adults with cerebral infarct (mean age of 39), accounting for 41% of all stroke etiology, followed by other causes in a quarter of those patients (131). Intracranial atherosclerotic disease predominated in the same young patients with large artery atherosclerosis, which involves the carotid circulation (middle cerebral artery and intracranial internal carotid artery) in approximately 70% of cases. Almost all patients with intracranial atherosclerotic disease had multiple modifiable stroke risk factors, with stroke due to large artery atherosclerosis increasing in proportion to the number of stroke risk factors (131). Nonatherosclerotic vasculopathy is a heterogeneous category that may account for 14% to 25% of stroke in younger patients (18; 149). Disorders in this category include focal cerebral arteriopathy (FCA) of childhood, Takayasu disease, fibromuscular dysplasia, cervical carotid and vertebral dissections, idiopathic or secondary forms of moyamoya disease, peripartum angiopathy, reversible vasoconstrictive syndromes, radiation-induced arteriopathy, non-amyloid vasculopathy, hyperhomocysteinemia, and others. In the International Pediatric Stroke Study, arteriopathy was identified on neurovascular imaging in 53% of children with arterial ischemic stroke (06). FCA was the most common type (25%), followed by moyamoya disease and syndrome, and arterial dissection. Recent upper respiratory tract infection was found to be a predictor for FCA, especially in children 5 to 9 years of age. Nevertheless, focal cerebral arteriopathy is a rare cause of ischemic stroke in young adults. Over a 4-month period, focal cerebral arteriopathy was identified as the sole cause of recurrent transient ischemic attacks or minor strokes in only three (2.4%) out of 123 patients aged 16 to 55 years. All three patients had multifocal cortical and basal ganglia infarcts at a mean age of 41 years. Angiography demonstrated unilateral focal proximal stenosis in the symptomatic carotid or middle cerebral artery, resolving completely or partially improving in two patients on control CT angiography. Varicella zoster IgG antibodies were positive in all patients, whereas all showed negative IgM serology results. All three patients received antiplatelet aggregation, intravenous corticosteroids, and acyclovir with a good functional outcome at discharge (113).

Fibromuscular dysplasia is the most frequent arterial dysplasia of the vertebral and carotid vasculature, typically affecting medium-sized arteries of young Caucasian females, most frequently the distal cervical and vertical petrous internal carotid arteries, V3 segments of the vertebral arteries, and the renal arteries (119). Fibromuscular dysplasia may lead to arterial dissection, aneurysm or fistula formation, thromboembolic phenomena, and hemodynamic failure in the affected arterial territory (140). The pathologic process results in rings of fibrous tissue and smooth muscle segments, producing the classical "string of beads" appearance on angiogram and arterial dissections and, less commonly, tubular stenosis and fusiform dilation (57).

Fusiform dilation in fibromuscular dysplasia (angiograms)

(A) Patient 1: Right common carotid artery injection, lateral view. Concentric irregularity and fusiform enlargement (“string of beads” appearance) of the distal cervical and vertical petrous internal carotid artery is consistent ...

Stroke can result from dissection as well as progressive arterial occlusion. In the Lausanne Stroke Registry, fibromuscular dysplasia accounted for 4% of strokes in patients 16 to 30 years old and 1% of strokes in patients 31 to 45 years (21).

Cervical arterial dissection accounts for 10% to 20% of ischemic strokes in young adults (163). Dissection may occur spontaneously or follow mild or severe trauma, chiropractic manipulation, surgical procedures, sudden head version, or neck hyperextension (163; 165). An underlying connective tissue disorder has been postulated in some cases (26). Dissection is associated with fibromuscular dysplasia, Marfan syndrome, Ehlers-Danlos syndrome type IV (133; 164), cystic medial necrosis, osteogenesis imperfecta, pseudoxanthoma elasticum, autosomal dominant polycystic kidney disease, alpha1-antitrypsin deficiency, redundancy of the internal carotid artery, lentiginosis, and infection (156; 165). A multicenter observational study assessed the relationship between the subtypes of migraine and cervical artery dissection (carotid or vertebral artery) in younger patients with stroke. Migraine--particularly without aura--was more frequent in patients with cervical artery dissection presenting with ischemic stroke (35%) than in patients with cerebral infarct not due to cervical artery dissection (27%). Both groups of patients had mild strokes (mean NIHSS score of 6; mean age of 44 years). The pathophysiology and causative relationship between migraine and cervical artery dissection remains to be fully understood (118).

The gold standard diagnostic modality remains cerebral angiography.

Internal carotid artery and vertebral artery dissections following left middle cerebral artery infarction

This patient is a 35-year-old man with left middle cerebral artery infarction 2 days after lifting heavy objects. Dissections are of both internal carotid arteries/both vertebral arteries by angiography. (A) Left common carotid ar...

Less invasive alternatives include CTA and MRI/MRA. CTA may demonstrate a filling defect suggestive of thrombus or intimal flap. A T1-fat-suppressed sequence should be requested on MRI to assess for extraluminal T1-hyperintense material suggestive of methemoglobin in the dissection flap. Level I evidence has not yet proven the sensitivity or specificity for these techniques. The overall prognosis for carotid dissections is better than that of vertebral dissections. In one group of patients, 76% of carotid dissections completely recovered neurologic function (123; 122), and less than 5% suffered fatal stroke or hemorrhage. Ten percent of patients with vertebral artery dissection die in the acute phase secondary to massive stroke or intracranial extension. The latter is usually associated with a dissecting pseudoaneurysm and has a worse prognosis than extracranial dissection (68; 20) due to a fulminant presentation with posterior fossa subarachnoid hemorrhage and a high rate of rebleeding.

Posterior fossa subarachnoid hemorrhage and pseudoaneurysm

(A) Head CT without contrast: subarachnoid hemorrhage in the posterior fossa, most dense in the prepontine cistern and fourth ventricle. (B) Digital subtraction angiography: left vertebral artery injection, lateral view. A dissect...

Pseudoaneurysm formation was more frequent in internal carotid dissections (22%) than in the vertebral artery (14%) in a series of 177 cervical artery dissection patients with a mean age of 44 (165). With the exception of dissecting vertebrobasilar pseudoaneurysms, recurrent dissection is rare: less than 2% in studies from academic centers and even lower in epidemiological studies (94; 165).

Spontaneous cervical artery dissection was identified in 123 individuals in a population-based retrospective observational cohort study covering the 19-year period from 2002 to 2020 (65). Mean age at the time of diagnosis was 50.2 years, and nearly half of patients were female. Arterial dissections involved the intracranial artery, vertebral artery, and common carotid artery in 51%, 44%, and 5% of patients, respectively, and 11% of patients had multiple cervical artery dissections. The most common clinical presentations were headache (50%) and cervical pain (30%), whereas 37% and 15% of patients presented with ischemic stroke and transient ischemic attack, respectively. Noninvasive vascular imaging was the preferred diagnostic imaging tool, with computed tomographic angiography used in 58% of patients (trending toward increased use over the final years), followed by magnetic resonance angiography in 54% of patients (65). The most common imaging findings were tapering stenosis (62%) and intramural hematoma on T1 fat-saturated MRI (25%). Arterial stenosis greater than or equal to 70% or occlusion was found in 45.6% of patients. Intravenous thrombolysis or endovascular therapy was given to 7% of patients in the hyperacute stroke period. Most patients started antithrombotic therapy after diagnosis. Anticoagulation was used principally from 2002 to 2011 and less often thereafter, whereas single or dual antiplatelet therapy was increasingly prescribed in more recent years. A good clinical outcome (a score of 0 to 2 on the modified Rankin Scale) within 2 years of diagnosis occurred in nearly 90% of patients, whereas both recurrent stroke (cerebral infarction or transient ischemic attack) and recurrent dissection occurred in 8% of patients (65).

The short- and long-term risk of dissection recurrence was prospectively assessed in 238 young adults with a first symptomatic cervical artery dissection (84). Diagnosis was established by fat-suppressed neck MRI sequences, digital subtraction angiography, or both. After diagnosis, patients received oral anticoagulation for 6 months followed by 6 months of antiplatelet therapy. Patients underwent Doppler ultrasound of cervical arteries at 3, 6, and 12 months after index event and had an additional ultrasound and brain MRI when a recurrent dissection was suspected. A skin biopsy was performed to identify connective tissue abnormalities in 105 patients (45%). A monophasic event (defined as a single event or as serial events) occurring within 1 month after the index dissection was observed in 221 patients (92%), with a mean age of 43.8 years. Arterial dissection predominantly affected the internal carotid artery in 65% of cases, and a single vessel in 188 patients (79%); 11 patients (5%) had dissection involving multiple vessels. On presentation, cerebral infarct was the main clinical manifestation in 164 patients (69%), whereas 11% of patients experienced a transient ischemic attack, and the remaining patients had local symptoms. Around half of these patients had abnormalities of connective tissue on skin biopsy. A recurrent dissection involving a different artery from the index event occurred in 22 patients (9%) while on antithrombotic treatment. Of these dissections, 61% were asymptomatic and 12% presented with cerebral infarct or transient ischemic attack (84).

A further recurrent dissection (1 month after the index event) was documented in 17 patients (7%) with a mean age of 38, 67% of whom had connective tissue abnormalities on skin biopsy. Recurrent dissection occurred between 2 and 6 months after index event in seven patients and 6 months after index event in 10 patients, whereas six patients had a recurrence only after 2 years. Ten patients were not on antithrombotic treatment when recurrence occurred (84). In 57% of cases, local symptoms predominated as clinical manifestation; 22% of new dissections (detected during ultrasound follow-up) were asymptomatic and 21% presented with cerebral infarct or transient ischemic attack. A good functional outcome was observed in patients with late recurrence.

Moyamoya disease is a noninflammatory vasculopathy most prominent in Asia (annual incidence is 0.35 per 100,000 Japanese inhabitants) (91) that usually affects children older than 6 years of age. Ratio of females to males affected is 1.8 to 1. Moyamoya disease is characterized by initially asymmetric, progressive, steno-occlusion of both supraclinoid internal carotid arteries and the circle of Willis that may result in recurrent ischemic or hemorrhagic strokes or seizures. Ischemic infarcts are more common in children; hemorrhagic infarcts are more common in patients older than 30 years of age (102). Six angiographic stages are described: stage I consists of supraclinoid internal carotid artery stenosis; stages II through V consist of progressive appearance then disappearance of moyamoya vessels; and stage VI consists of external carotid artery branches supplying the intracranial circulation due to occlusion of the major intracranial vessels (181). The posterior cerebral arteries are spared until late in the disease. The classic angiographic appearance is a faint blush of contrast akin to "a puff of smoke" secondary to the development of multiple, fragile collateral vessels in the basal ganglia and thalami that are prone to hemorrhage.

Leptomeningeal collaterals and basal moyamoya vessels in patient with involuntary movements after gastroenteritis

Angiography in an 18-year-old girl with involuntary right-sided movements following an episode of gastroenteritis. (A) Left vertebral artery, lateral injection: numerous leptomeningeal collaterals from the left posterior temporal ...

Two additional subtypes of moyamoya may manifest late in the disease: ethmoidal (180) and vault (85). The former is primarily supplied by the ophthalmic artery and posterior and anterior ethmoidal arteries. The latter is supplied by transdural anastomoses from the middle meningeal or superficial temporal arteries. Moyamoya disease is associated with a number of systemic conditions, including sickle cell disease, Down syndrome, neurofibromatosis type I, radiation therapy, neonatal anoxia, coarctation of the aorta, and certain infections such as tuberculosis (203; 205). Surgical revascularization procedures include superficial temporal artery-middle cerebral artery (STA-MCA) bypass or rarely, superficial temporal artery-anterior cerebral artery (STA-ACA) bypass, occipital artery-middle cerebral artery (OA-MCA) bypass, encephaloduroarteriosynangiosis (EDAS), or encephaloduroarteriomyosynangiosis (EDAMS) (205; 91).

Internal carotid artery occlusion and vault moyamoya (angiography)

Angiography in a 57-year-old woman with left middle cerebral artery infarction and hemorrhagic transformation. (A) Right internal carotid artery (ICA) injection, lateral view. The supraclinoid right ICA is occluded. Right middle c...

Stroke from reversible cerebral arterial vasoconstriction or Call-Fleming syndrome, is gaining recognition (173; 169; 170; 30). It has been described in a variety of conditions, including pregnancy and the puerperium (postpartum angiopathy), migraine, use of vasoconstrictive drugs, reversible posterior leukoencephalopathy, blood transfusions, tumors (eg, phaeochromocytoma), medical conditions (hemolysis, antiphospholipid syndrome, thrombotic thrombocytopenic purpura), and benign angiopathy of the central nervous system (120). In a retrospective analysis of 139 patients at two academic centers that included cases of “probable” reversible arterial vasoconstriction syndrome, the patients were predominantly female (80%) and had a mean age of 42 (174). One third of these patients had a history of vasoconstrictive drug exposure and 6% were recent postpartum patients. Forty-three percent of patients had focal neurologic deficits. Brain ischemia (often watershed rather than territorial infarcts) was documented in around 40% of patients. Subarachnoid hemorrhage overlying the hemispheric convexity was found in 34%; and 20% of patients had lobar hemorrhage. Arterial narrowing (most often by transfemoral or CT angiography) was severe in nearly all patients, even in the absence of cerebral lesions on brain imaging, and complete resolution of the stenosis in the angiographic follow-up occurred in around 70% of patients. A good outcome was observed in 90% of patients, and only 2% of patients died. Out of 159 patients aged 18 to 45 years who were admitted in a stroke unit with acute cerebral infarct found on brain MRI, 21 patients (13%) had multifocal segmental stenosis (mean of 4.52 per patient) in at least two different intracranial arteries on 3D-TOF-MRA or CTA performed on the day of admission and ended up with proven spontaneous reversibility of all segmental stenosis within 3 to 6 months. This finding was the only abnormality observed, despite an extensive etiological investigation, and was considered by the authors to be a variant of a reversible vasoconstriction syndrome (201). These patients had a number of differences compared with others reported in large series of reversible arterial vasoconstriction syndrome: they were younger (mean age of 32) and predominantly male; they showed a higher frequency of traditional stroke risk factors; 74% of them had unusually severe headaches during a mean of 9 days before the onset of stroke; and none of them had the classically recurrent thunderclap headache. A precipitating factor (mostly cannabis use) was identified in 81% of these patients and cerebral infarcts were found in all of them on neuroimaging studies, with territorial infarcts predominating in the posterior circulation. At 3 months all patients showed a good outcome (201).

Misdiagnosis is common because clinical and radiological features may overlap with primary cerebral vasculitis. The preeminent factors for distinguishing between reversible cerebral vasoconstriction syndrome and primary angiitis of the central nervous system can be an explosive onset or worst-ever headache with recurrent thunderclap headaches in the next few days, the clinical setting, the type and location of brain lesions, and normal cerebrospinal fluid results (174).

Common causes of cardiac emboli in the young include prosthetic heart valves, rheumatic valvular disease, bacterial endocarditis, atrial septal aneurysm, patent foramen ovale, dilated cardiomyopathy, ischemic dyskinetic segments, atrial myxomas, and mitral valve prolapse. Less common sources of cardiac emboli are nonbacterial thrombotic (marantic) and Libman-Sacks endocarditis. Marantic endocarditis is characterized by multiple, sterile, fibrin or platelet thrombi adherent to the mitral and aortic valves, usually in patients with mucin-secreting malignancies. Libman-Sacks endocarditis occurs in patients with systemic lupus erythematosus and is characterized by verrucous, fibrinous lesions of the mitral and aortic valves, leading to valvular insufficiency.

Rheumatic fever remains the most common cause worldwide of acquired heart conditions in the young and an eminently preventable etiology of stroke. The mitral valve is most frequently affected, followed by the aortic valve. The lifetime risk of embolism with rheumatic mitral stenosis is 20%; cerebral embolism is present in 60% of these cases and is more likely if atrial fibrillation, left atrial enlargement, low cardiac output, or severe mitral stenosis is present (19). Rheumatic fever should be suspected with clinical manifestations such as fever, arthralgia or arthritis, painless subcutaneous nodules, chorea, or erythema marginatum following tonsillopharyngitis. Pharyngeal cultures growing beta-hemolytic streptococcus or serum streptococcal antibody titers are diagnostic. Less commonly, ischemic stroke may be associated with the tetralogy of Fallot, Eisenmenger complex, patent ductus arteriosus, or other cardiac valvular anomalies. The prevalence of cardiac abnormalities in the asymptomatic population must be considered when attributing cause to stroke in a younger population. This is particularly true for a high-prevalence condition such as mitral valve prolapse, which may be no more common in stroke patients (1.9%) than in controls (2.7%) (61). One referral center study reported a 24% to 29% proportion of ischemic strokes attributed to cardiac embolism (02). A population-based study reported a 28% to 31% proportion of ischemic strokes attributed to cardiac embolism (69). The variability in estimates (from 10% to 40%) may be due to extent of cardiac evaluation. Transesophageal echocardiography may be superior to transthoracic echocardiography for the detection of a cardiac source of cerebral embolism (112; 124) due to improved visualization of left atrial appendage thrombi, valvular vegetations, atrial septal aneurysms, and patent foramen ovale with the latter. The addition of Doppler color flow studies is especially useful to assess structural features and flow characteristics of prosthetic heart valves.

Paradoxical embolization is a presumed cause of so-called cryptogenic stroke in the young. Patent foramen ovale is more frequently found in patients with cryptogenic stroke than in those with known etiology or in healthy control patients. A thorough work-up should be undertaken to identify a venous source of emboli to traverse the shunt; if absent, the presence of a patent foramen ovale should only be considered a possible cause for the stroke (43). Patients with both a patent foramen ovale and atrial septal aneurysm have a much higher stroke risk than patients with either one of these conditions (OR 23.93; 95% CI: 3.09-185.42) (112; 141). Spontaneous echo contrast is found in up to 9% of transesophageal echocardiograms in young stroke patients (49). Although its significance is unclear, it is caused by sluggish left atrial blood flow and is more common in atrial fibrillation.

Characteristics of cardioembolic stroke include abrupt onset of neurologic deficit maximal at onset that is often triggered by activity. Association with Valsalva maneuver or acute pulmonary hypertension may also suggest paradoxical embolism (19). Prior transient ischemic attacks in the same arterial territory are unlikely. A good history should evaluate for episodic palpitations, lightheadedness, or a history of sick sinus syndrome or atrial fibrillation (40). Although nearly half of cardioembolic strokes are related to atrial fibrillation, the latter is found in only 0.4% of adults younger than 60 years of age (19). In the last few months, after prolonged cardiac monitoring, the prevalence of previous or de novo atrial fibrillation was found to be 9% (14 patients, eight with paroxysmal atrial fibrillation and five with permanent atrial fibrillation) among 157 young adults with brain infarction (mean age of 43, 60% males). In this series, atrial fibrillation was more commonly associated with valvulopathy or cardiomyopathy (143). In another study that included long-term ECG Holter monitoring performed after a median of 39 days from admission for the index event, a 10% rate of atrial fibrillation was found in 98 patients aged 18 to 49 with acute cerebral infarct. The mean time from start of long-term ECG Holter monitoring to detection of arrhythmia (mainly in paroxysmal form) was 11.5 days. In contrast to Prefasi’s series, structural heart disease was found in only 10% of the atrial fibrillation patients. These patients had an elevated level of acute serum cardiac markers (N-terminal probrain natriuretic peptide and high sensitive troponin T). N-terminal probrain natriuretic peptide may be a predictor of atrial fibrillation (160).

Table 2. Conditions Associated with Cardiac Emboli

Probable source
	• Endocarditis • Atrial fibrillation • Recent myocardial infarction • Akinetic segment • Dilated cardiomyopathy • Intracardiac thrombus • Cardiac tumors
		- Atrial myxoma - Cardiac rhabdomyoma - Cardiac papillary fibroelastoma
	• Sick sinus syndrome • Valvular vegetations including nonbacterial thrombotic endocarditis
		- Nonbacterial thrombotic endocarditis - Libman-Sacks endocarditis
	• Rheumatic valvular disease • Prosthetic valve • Right-to-left shunt with associated venous thrombosis • Spontaneous atrial contrast echo • Atrial septal aneurysm • Intracardiac tumors • Recent cardiac procedures
		- Bypass graft - Valvular surgery - Heart transplantation - Extracorporeal membrane oxygenation (ECMO)
Possible source
	• Mitral valve prolapse • Atrial flutter • Remote myocardial infarction • Left ventricular hypertrophy • Hypokinetic segment • Atrial septal aneurysm • Isolated atrial septal defect or patent foramen ovale (without associated venous thrombosis) • Mitral annular calcification • Calcific aortic stenosis • Coarctation of the aorta • Mitral valve strands • Aneurysm of the sinus of Valsalva • Left ventricular aneurysm
Adapted from (178).

The spectrum of hematologic causes of stroke includes primary hypercoagulable syndromes and secondary hypercoagulable states. Primary hypercoagulable states are caused by quantitative or qualitative abnormalities of specific coagulation proteins leading to a lifelong predisposition to thrombosis. Secondary hypercoagulable states, a diverse group of mostly acquired conditions, cause a prothrombotic state by complex mechanisms (125). Ischemic stroke can be the presenting feature of a hematologic disorder (Table 3). A hypercoagulable state accounts for 1% to 2% of all stroke and 2% to 7% of stroke in patients younger than 50 years. The inherited thrombophilias (ie, protein C, S, and antithrombin deficiencies) are relatively common at 1:200 to 1:2000 in the heterozygous form, but the frequency of symptomatic deficiency is only 1:36000 (64; 110). Symptomatic episodes are usually venous thromboses; hereditary deficiencies of proteins C, S, or antithrombin III are rare in ischemic stroke patients younger than 45 years (52). Resistance to activated protein C due to a mutation in factor V (factor V Leiden) and a mutation in the prothrombin gene (20210A) have been shown to be important genetic risk factors for venous thromboembolic disease, including cerebral venous thrombosis (111), but less likely for arterial ischemic stroke (209). One study determined the odds ratio for carriers of factor V Leiden mutation compared to noncarriers to be 2.56. Relationship with the factor V Leiden mutation was greater in women (odds ratio 3.95), and the combined presence of factor V Leiden mutation plus at least one vascular risk factor increased the odds ratio to 10.72 (107). An important note is that acute thrombosis itself may cause transient decreases in proteins C, S, and antithrombin. The acute evaluation for these deficiencies, therefore, may yield inaccurate results. Also, heparin has been found to lower antithrombin levels, and warfarin lowers functional levels of protein C and S. Conditions with hematologic changes possibly leading to stroke include pregnancy, cancer, nephrotic syndrome, leukemia, inflammatory bowel disease, acute infection, paroxysmal nocturnal hemoglobinuria, and Behçet syndrome. Finally, antiphospholipid antibodies have been associated with ischemic stroke in some studies; however, their causative role in stroke is not entirely clear (27). To estimate the frequency of any antiphospholipid antibodies (aPL) in patients with stroke between 16 and 50 years of age (median age of 37), Sciascia and coworkers identified 5217 patients (3349 stroke patients and 1868 controls) included in 43 studies (six prospective studies with 408 patients) in a systematic review of available relevant papers in electronic databases from 1970 to 2013 (166). In young stroke patients, the frequency of any antiphospholipid antibody was 17%; anticardiolipin antibodies (aCL), lupus anticoagulant, and anti-β2 glycoprotein 1 antibodies were found in 22%, 16%, and 14% of these patients, respectively. Despite significant heterogeneity and methodological flaws observed in the studies included, the authors maintain that the results suggest a robust association between antiphospholipid antibody and stroke when compared with young control individuals. Accordingly, an antiphospholipid antibody positivity test may be associated with a 5-fold higher risk for cerebrovascular event (ischemic stroke or transient ischemic attack). A hypercoagulable screen is warranted when venous thrombosis with paradoxical embolism is suspected, when there is a family history of recurrent thrombosis, or when there is a personal or family history of recurrent miscarriage.

Table 3. Selected Hematologic Disorders Associated with Stroke

	• Sickle cell disease • Hemoglobin SC disease • Polycythemia • Hyperviscosity state • Thrombocytosis • Heparin-induced thrombocytopenia • Iron deficiency anemia • Thrombotic thrombocytopenic purpura • Paroxysmal nocturnal hemoglobinuria • Hyperhomocysteinemia and homocystinuria • Disseminated intravascular coagulation • Antiphospholipid antibodies
		- Lupus anticoagulant - Anticardiolipin antibodies
	• Antithrombin deficiency • Protein C deficiency • (Free) Protein S deficiency • Activated protein C resistance (including, but not limited to, Factor V Leiden mutation) • Disorders of fibrinolysis • Methylene tetrahydrofolate reductase (MTHFR) mutation C677T • Plasminogen activator promoter polymorphism (PAI-1) • Prothrombin gene 20210A mutation
Adapted from (178).

Multiple drugs, illicit and otherwise, have been associated with stroke, including over-the-counter sympathomimetics such as phenylpropanolamine, ephedrine and pseudoephedrine, amphetamines, alcohol, heroin, cocaine, phencyclidine, lysergic acid diethylamide, marijuana, and synthetic cannabinoids (“spice”) (78; 202). Up to 14% of ischemic and hemorrhagic infarcts in individuals aged 18 to 44 years were caused by substance abuse in a study (199). Patients may not provide an accurate history regarding substance abuse; therefore, a complete physical examination, including skin exam for presence of needle marks, should raise suspicion for drug abuse. Blood and urine toxicology should also be obtained. The possibility of septic endocarditis should also be considered in the intravenous drug abuser. Based on a valid and reliable inpatient-care database from a United States data source, recreational marijuana use was found to be independently associated with ischemic stroke in a retrospective analysis (from 2004 to 2011) of patients aged 15 to 54 years (158). Compared with non-users, recreational marijuana users had a 17% higher probability of hospitalization due to acute cerebral infarction in all stratified age groups of individuals between 15 and 54 years. This probability was even higher when marijuana use was combined with tobacco use (31%) or cocaine use (42%).

In a retrospective single-center study of 250 patients with intracerebral hemorrhage, 16% (41) had a urine drug screen that tested positive for methamphetamine, and four of these patients had a positive screening for cocaine and opioids as well (182). Compared with methamphetamine-negative intracerebral hemorrhage patients, the patients with methamphetamine-associated intracerebral hemorrhage were 15 years younger on average (mean age of 52 years), had a significantly higher mean arterial pressure at admission, and a longer intensive care unit and hospital stay. Mean intracerebral volume was slightly higher in methamphetamine-positive patients (25 vs. 22 mL), and subcortical hemorrhages (63%) were significantly more prevalent than other hemorrhage locations (the other 37% were located variously in the cerebral lobes, brainstem, and cerebellum) (182).

Stroke is a rare complication of migraine (189; 36). The overall incidence of migraine-associated stroke is 3.36 per 100,000 per year. In individuals without other stroke risk factors, the incidence decreases to 1.44 per 100,000 per year. Migraine with aura and the subtypes of migraine, such as familial hemiplegic migraine, and basilar, retinal, and ophthalmoplegic migraine have a higher stroke risk. Several case-control studies have demonstrated an approximately 4-fold higher stroke risk in women with migraine under age 45 years; within this population, the risk increases to 10-fold in smokers and 14-fold in those taking oral contraceptive pills. The risk is highest (odds ratio of 34) in young women with migraine who smoke and take oral contraceptive pills. This association is inconsistent in older women and men. Given the high prevalence and incidence rates of migraine (10% to 25%) and ischemic stroke and the high prevalence of headache in patients with stroke, it is important to distinguish between (1) stroke of another cause coexisting with migraine, (2) stroke of another cause (eg, carotid artery dissection) presenting with clinical features of migraine with aura, and (3) stroke occurring during the course of a typical attack of migraine with aura (198). The aura of migraine is a key risk factor for cerebral ischemia. Stang and colleagues found that migraine with aura was strongly associated with verified stroke (O.R. 2.81) as well as symptoms of stroke (O.R. 5.46) and symptoms of TIA (OR 4.28); the association was not significant in patients with headache without aura (176). In the last few months, a large population-based study of Asian patients has come to light that assessed the incidence of ischemic stroke in a neurologist-diagnosed migraine cohort of 119,017 patients aged over 20 years and a nonheadache-matched comparison cohort (119,017 individuals) (137). After a mean follow-up of 3.6 years, the migraine-cohort patients showed a risk of ischemic stroke 1.24 times higher than the comparison-cohort individuals. Moreover, in female aural migraine patients younger than 45, the risk of cerebral infarct was six times higher.

The mechanisms underlying the relationship between migraine and cerebral ischemia are not yet well understood. Migraine-specific mechanisms, potential common biological mechanisms (endothelial dysfunction, patent foramen ovale, and hypercoagulability), atherosclerotic mediated mechanisms, and genetic influence –likely all acting synergistically– might be operating to increase the propensity of cerebral ischemia in migraine (138). Young age, female sex, a history of “high-risk” migraine subtypes (eg, familial hemiplegic migraine), cigarette smoking, use of oral contraceptives, onset with typical but perhaps more severe migrainous headache, prolonged aura, spreading or marching symptoms, visual and cortical symptoms, and posterior circulation infarct on brain imaging are factors that raise suspicion for migrainous stroke. Criteria for the diagnosis of migraine-induced stroke include: (1) previously established diagnosis of migraine with aura, (2) onset of infarction occurring during the course of a typical migraine aura attack, (3) persistent aura symptoms for more than 60 minutes, (4) evidence of ischemic infarction in relevant location by neuroimaging, and (5) no other obvious cause of infarction (70).

Migrainous infarction accounts for 13.7% of ischemia in young adults (09). Migraine-associated acute cerebral ischemia was identified in 17 individuals (11 having migraine with aura) in a prospectively collected data set of 8137 stroke patients over an 11-year period, amounting to an estimated frequency of around two cases per 1000 strokes per year (200). These patients were younger women with a longstanding (mean of 13 years) history of migraine and prolonged aura symptoms. Moreover, a high prevalence of patent foramen ovale was identified and lesions were small, most often involving the posterior circulation. The overall outcome was favorable (200). Therefore, migrainous infarction is a diagnosis of exclusion. Because migraine is a clinical diagnosis without a diagnostic marker or unique radiographic features, alternative etiologies such as arteriovenous malformation, cervical arterial dissection, antiphospholipid syndrome, MELAS, or cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) should be pursued if the presentation is not highly consistent.

Infection (particularly chlamydia and HIV) and acute and chronic inflammation have been attributed to raising stroke risk in younger patients (25; 103; 142; 146; 104; 08; 41). A population-based study found AIDS to be a major risk factor for ischemic as well as hemorrhagic stroke (41). In a nationwide population-based cohort study, HIV-infected individuals had an increased risk of stroke compared to their controls (148). The relative risk was substantially higher in the injection-drug-abuse HIV-infected individuals (35.6 median years), particularly for intracerebral and subarachnoid hemorrhage. High stroke risk was further associated with low CD4 cell count before the start of HAART, and also with abacavir treatment, although not with HAART, in general. Diagnostic considerations in the infection setting include meningovascular syphilis; nonbacterial thrombotic endocarditis with cardiogenic embolism; vasculopathies associated with cryptococcal, tuberculous, and lymphomatous meningitis; toxoplasmosis; and herpes zoster.

Stroke can result from inherited disorders such as MELAS and CADASIL. MELAS is a disorder of mitochondrial metabolism resulting from a point mutation in mitochondrial DNA encoded transfer RNA for leucine. The pathology of stroke remains unclear. Patients typically present with ischemic-appearing lesions that are not restricted to a single arterial vascular territory, migraine-like headaches, seizures, emesis, and lactic acidosis and may have myopathy, ataxia, cardiomyopathy, diabetes, retinitis pigmentosa, or renal abnormalities. Muscle biopsy reveals ragged red fibers. Patients with CADASIL typically present with recurrent subcortical strokes (76; 109). Specific mutations in the notch 3 gene on chromosome 19 have been identified in patients with CADASIL. Brain MRI typically reveals a diffuse leukoencephalopathy with infarcts in the basal ganglia and white matter bilaterally, extending into the anterior temporal lobes and external capsules. Cerebral microhemorrhages are common (193). Imaging abnormalities can precede stroke-like symptoms by several years. Diagnosis is made by skin biopsy. Another condition associated with stroke is Hashimoto encephalopathy with cerebral vasculitis. Clinical presentation includes relapsing and remitting neurologic symptoms and signs of seizures, myoclonus, stroke-like episodes, cognitive decline, and neuropsychiatric manifestations (121). Some migraine patients may present with headache, reversible neurologic deficits, and recurrent cerebrospinal fluid lymphocytosis (HaNDL) syndrome; their neuroimaging studies are normal (56).

Fabry disease, or Anderson-Fabry disease, is an X-linked recessive lysosomal storage disorder due to alpha-galactosidase-A deficiency (mutation of the gene at Xq22.1) leading to a glycosphingolipid accumulation in neurons and vascular endothelial and smooth muscle cells. Men and women are similarly affected, with a wide range of clinical manifestations from asymptomatic states to irreversible organ failure.

Fabry disease affects the peripheral and central nervous systems, as well as the myocardium, kidney, and the gastrointestinal system. Nonneurologic clinical manifestations on the skin (angiokeratoma corporis diffusum), corneal opacity (cornea verticillata), subcapsular cataracts, hypohidrosis, and acroparesthesias often develop in childhood or adolescence, although they may occasionally be absent in young adults, making the diagnosis of Fabry disease a challenge. Stroke is the leading complication of Fabry disease in the central nervous system. The leading complication of Fabry disease is stroke (168). Cerebral infarcts and transient ischemic attacks are the most prevalent stroke subtypes, sometimes presenting as the first manifestation of this disease, thus, leading to its diagnosis. Large vessel and small vessel symptomatic infarcts are most common, although chronic white matter hyperintensities, usually asymptomatic, may also be found on neuroimaging studies. Intracerebral or subarachnoid hemorrhages, microbleeds, and cerebral venous thrombosis are less common occurrences in Fabry disease (88).

Fabry disease is considered an uncommon, though treatable, cause of stroke. The stroke pathogenesis associated with Fabry disease is incompletely understood, despite its association with arterial ectasia, endothelial dysfunction, premature atherosclerosis, and cardiopathy (hypertrophic and restrictive cardiomyopathies, valvular and conduction-system abnormalities). In a meta-analysis of nine studies (eight ranked moderate to high quality by a designed assessment tool; four studies focusing on cryptogenic stroke and the remainder on all stroke etiologies) comprising around 8000 patients with a mean age range between 38 to 51 years, the prevalence of Fabry disease was higher in patients with cryptogenic stroke (0.6% to 11%), whereas it ranged from 0.4% to 2.6% in stroke of any etiology. A male predominance in the prevalence of Fabry disease was observed in cryptogenic stroke (4.5% vs. 3.4% in women), but no gender difference in the prevalence of Fabry disease was observed when stroke of any etiology was considered.

Moreover, the incidence of definite or probable Fabry disease was estimated in a prospective multicenter observational study (47 centers in 15 European countries) that included 5023 patients from 18 to 55 years of age (median age of 46) presenting a recent cerebrovascular event (within 3 months; brain infarct in 71% of patients; transient ischemic attack in 22%; intracerebral hemorrhage in 5%) (155). In this largest cohort of young stroke patients, Fabry disease was present in 1% (0.5% definite and 0.4% probable diagnosis). Females, younger patients, and ischemic stroke predominated in both diagnostic categories. Territory infarcts were found in 40% and 33% of definite and probable Fabry disease patients, respectively. Interestingly, no association was found between Fabry disease with cardiopathy (congestive heart failure or arrhythmia), and family history of cardiac, renal, or cerebrovascular disease (155).

Many other disorders have been associated with cerebral infarction in the young. Some possible entities are listed in Table 4.

Table 4. Other Conditions Associated with Stroke

Inflammatory diseases:
	• Rheumatoid arthritis • Systemic lupus erythematosus • Scleroderma • Sjögren syndrome • Polymyositis • Proximal myotonic myopathy • Henoch-Schönlein purpura • Polyarteritis nodosa • Churg-Strauss syndrome • Wegener granulomatosis • Lymphomatoid granulomatosis • Sarcoidosis • Primary vasculitis of the central nervous system • Behçet disease
Infectious diseases:
	• Neuroborreliosis • Neurocysticercosis • Varicella zoster • HIV • Bacterial (pyogenic) meningitis • Chlamydia pneumonia • Hepatitis C virus and mixed cryoglobulinemia • Hydatid cyst embolism • Leptospirosis
Cancer:
	• Tumor emboli • Malignant angioendotheliomatosis
Hereditary disorders:
	• Neurofibromatosis • Epidermal nevus syndrome • CADASIL • Sneddon syndrome • Williams syndrome
Medication-related:
	• Ovarian hyperstimulation syndrome or high-dose female sex hormone therapy • L-asparaginase • High-dose intravenous immunoglobulin • Methotrexate • Interferons
Other:
	• Fibrocartilaginous embolism • Childhood cerebral arteriopathies • Dysplastic arteriopathies/arterial abnormalities (PHACES syndrome, Alagille syndrome, Williams Syndrome, Noonan syndrome, and trisomy 21) • Hashimoto encephalopathy with vasculitis • Headache, neurologic deficits, and cerebrospinal fluid lymphocytosis (HaNDL) syndrome
	Adapted from (178).

The majority of intraparenchymal hemorrhages are lobar; they may also occur in deep subcortical structures (basal ganglia, internal capsule), brainstem, or cerebellum, depending on etiology (47; 157). In a study of intracerebral hemorrhage in young adults, ruptured arteriovenous malformations were found in 29%; hypertension in 15%; ruptured aneurysms in 10%; miscellaneous conditions in 22%; and undetermined causes in 24% (184). Another study of intracerebral hemorrhage in young people noted vascular malformations in 49% of patients; hypertension in 11%; cerebral venous thrombosis in 5%; sympathomimetic drug use in 4%; toxemia of pregnancy in 4%; and cryptogenic cause in 15% (157). Excluded from this study were primary subarachnoid hemorrhage, trauma, past evidence of vascular malformation, and brain tumor. The importance of repeat vascular imaging (ideally catheter angiography) after an interval of 8 to 12 weeks to allow for resolution of intracranial blood products cannot be overstated as repeat workup of intraparenchymal hemorrhages in young adults without vascular risk factors often yields a previously occult vascular malformation.

Medial left frontal intraparenchymal hemorrhage and bilateral intraventricular hemorrhage (angiography)

(A) 38-year-old man with medial left frontal intraparenchymal hemorrhage and bilateral intraventricular hemorrhage. Two cerebral angiograms, head CTA and head MRI head without and with gadolinium during the initial hospitalization...

Selected causes of hemorrhagic events are listed in Table 5. Normotensive patients with lobar hemorrhages are especially likely to have an underlying vascular lesion (see Vignette 3). Patients with cavernous malformations occasionally have a familial history, as do 20% to 30% of individuals with an aneurysm (67). Familial aneurysms are more common in women below the age of 50 years (93). Disorders associated with intracranial saccular aneurysms include autosomal dominant polycystic renal disease, pseudoxanthoma elasticum, Ehlers-Danlos type IV, Marfan syndrome (possibly), neurofibromatosis, coarctation of the aorta, arteriovenous malformations, and moyamoya disease. Mycotic aneurysms represent 4% of all intracranial aneurysms and occur in 3% of patients with infective endocarditis (55). They may be saccular or fusiform and frequently occur in distal branches of the middle and posterior more than anterior cerebral arteries. Due to the peripheral location, mycotic aneurysm rupture frequently results in intraparenchymal, not subarachnoid, hemorrhage.

Table 5. Selected Causes of Spontaneous Intracranial Hemorrhage

	• Trauma
	• Aneurysm
		- Berry - Mycotic - Dissecting pseudoaneurysm
	• Vascular malformation
		- Arteriovenous malformation (AVM) - Dural arteriovenous fistula (dAVF) - Cavernous malformation
	• Hypertension • Coagulopathy • Arteritis
		- sterile - infectious
	• Sympathomimetic drugs
		- cocaine and crack cocaine - fenfluramine and phentermine - phenylpropanolamine, ephedrine/ephedra
	• Hemorrhage into a tumor • Moyamoya disease or syndrome • Hereditary intracerebral hemorrhage
		- Dutch type (mutation in amyloid precursor protein gene) - Icelandic type (mutation in cystatin C)
		Adapted from (178).

Unfortunately, even after an exhaustive evaluation for etiology of stroke in the younger patient, up to 40% of cases remain without a known etiology. In a survey of ischemic stroke in the young, 44% of patients had known cause of stroke, although one in five of these patients may have been inadequately investigated, resulting in a spuriously high percentage of cryptogenic cases (35). A complete diagnostic evaluation is, therefore, critical in order to determine potential causes and effective secondary stroke-prevention strategies.

Diagnostic workup

A careful patient history, physical examination, and laboratory evaluation, as well as specific diagnostic techniques in appropriate patients can elucidate many etiologies of stroke in this group of patients. The history can provide clues to the cause of the stroke. A history of deep venous thrombosis or miscarriage may alert the physician to an occult coagulation abnormality. Repeated questioning of patients and family members regarding possible illicit drug use may clarify this issue. Subtle head trauma or rapid or prolonged head and neck extension may be helpful historical points. A family history of headache or early onset stroke may be relevant as well. The physical examination should include a careful evaluation of the cardiovascular system and skin, a formal ophthalmologic evaluation (Table 6), and a complete neurologic assessment.

Table 6. Clues from Examination of the Eyes and Skin

Examination	Finding	Possible cause
Eyes	Corneal arcus	Hypercholesterolemia
	Corneal opacity	Fabry disease
	Lisch nodules	Neurofibromatosis
	Lens subluxation	Marfan syndrome, homocystinuria
	Retinal perivasculitis	Eales disease, Behçet disease, syphilis, connective tissue diseases, sarcoidosis, inflammatory bowel disease
	Retinal arteriolar occlusions	Emboli, microangiopathy with sensorineural hearing loss and multiple small strokes
	Retinal angioma	Cavernous malformation, von Hippel-Lindau disease
	Optic atrophy	Neurofibromatosis
	Retinal hamartoma	Tuberous sclerosis
	Yellow white placoid lesions at pigment epithelium and choroid of the retina	Acute posterior multifocal placoid pigment epitheliopathy
Skin	Osler nodes, splinter hemorrhages, needle tracks	Infective endocarditis
	Xanthoma, xanthelasma	Hyperlipidemia
	Cafe-au-lait spots, axillary and inguinal freckles, neurofibromas	Neurofibromatosis
	Thin, fragile skin with easy bruising, bluish sclera	Ehlers-Danlos syndrome type IV
	Telangiectasia	Osler-Weber-Rendu disease, scleroderma
	Purpura	Coagulopathy, Henoch-Schönlein purpura, cryoglobulinemia
	Capillary angioma	Cavernous malformation
	Aphthous or genital ulcers	Behçet disease
	Angiokeratomas	Fabry disease
	Livedo reticularis	Sneddon syndrome
	Facial angiofibromas, ash leaf spot, ungual fibroma, shagreen patch	Tuberous sclerosis
	Papules, atrophic lesions	Degos disease (malignant atrophic papulosis)
	Lentiginosis	Dissection
	Yellow-orange papules/plaques (resembling xanthomas)	Pseudoxanthoma elasticum
Adapted from (178; 33).

An organized and stepwise evaluation should follow as needed regarding ancillary testing. Complete blood count with differential, erythrocyte sedimentation rate, electrolytes, glucose, coagulation panel, platelet count, liver and renal function tests, lipid panel, and pregnancy test (if appropriate) are routinely performed (172). Specialized investigations to rule out specific etiologies in young adults with stroke may involve toxicological, rheumatological, infectious, hematological, and hypercoagulable panel tests, CSF examination, advanced brain-imaging techniques, brain and leptomeningeal biopsy, and genetic tests (172).

Neuroimaging with a CT or MRI (preferred) of the head can confirm the diagnosis and differentiate between an ischemic stroke and a hemorrhagic event. A carotid ultrasound can evaluate for high-grade stenosis of a symptomatic vessel, whereas transcranial Doppler, CT angiography, or MR angiography may be useful to evaluate the intracranial vasculature for stenosis or collateral flow. Transcranial Doppler sonography can increase the detection of right-to-left intracardiac shunts. Cerebral angiography remains the most sensitive method of vascular imaging and is particularly useful when a dynamic evaluation of the intracranial circulation is required (eg, hemodynamically significant stenosis, leptomeningeal collateral supply, venous hypertension, or early venous drainage from a vascular malformation). Further evaluation should be performed as indicated, based on the suspected stroke etiology. A cerebrospinal fluid sample should be obtained when vasculitis is suspected or when the history is concerning for subarachnoid hemorrhage and the CT is unrevealing. CT and MR venography (CTV and MRV) are useful for evaluating cerebral venous thrombosis, particularly when a sinus is involved. If cortical venous thrombosis is strongly suspected, despite a negative head CTV/MRV, a diagnostic cerebral angiogram should be performed. When a cardiac embolus is the suspected etiology of cerebral infarction in a young adult, echocardiography should be the primary form of cardiac imaging. Echocardiographic techniques may be helpful to rule out a cardiac source of embolism and may also influence future secondary stroke prevention, depending on high or low risk of cerebral embolism between the different types of cardiopathy. In this setting, transesophageal echocardiography is superior to transthoracic echocardiography for identifying potential cardiac sources of embolism (such as prosthetic valve abnormalities, native valve vegetation, atrial septal anomalies, and thrombus in the left atrium and the left atrial appendage as well as tumors and spontaneous echocardiographic contrast) in young patients with ischemic stroke. Transesophageal echocardiography is a safe, semi-invasive procedure with a low rate of complications, the most serious of which is esophageal perforation (with an incidence of up to 0.09% in all studies performed) (161).

Transcranial Doppler sonography can increase the detection of right to left intracardiac shunts (186). In patients with patent foramen ovale, pelvic MR venography can uncover pelvic vein thrombosis as the source of blood clots (43). Cerebral angiography often provides a wealth of information and remains the most sensitive vessel imaging method. Further evaluation should be performed as indicated, based on the suspected stroke etiology. For example, a cerebrospinal fluid sample should be obtained when vasculitis is suspected or when the history is concerning for subarachnoid hemorrhage and the CT is unrevealing.

The diagnostic yield of tests in 215 young adults (mean age of 37) with cerebral infarct involving the anterior (65%) and posterior (30%) circulation has been reported. An extensive diagnostic workup, including prothrombotic and vasculitis panel, toxicology screening, CSF examination, Holter monitoring, echocardiography, and neuroimaging, was performed in almost all patients (75). Cerebral angiography disclosed an embolic occlusion, severe stenosis, or other vasculopathy, mainly in the proximal segment of the middle cerebral artery, in 64% of the patients. Echocardiography (contrast transthoracic in 91% and transesophageal in 40%) was abnormal in half of the patients; patent foramen ovale was the most common abnormality, affecting 96 patients, and was the only finding in 83 patients; in 76, it was implicated as stroke etiology. Screening for hypercoagulable state gave a diagnostic yield of 16%; functional protein S deficiency and prothrombin 20201 mutation were the most and least commonly observed abnormalities, respectively. Cerebrospinal fluid examination was abnormal in 15% of the patients. A low diagnostic yield (less than 5%) was observed in both toxicological screening and vasculitis panel whereas Holter monitoring had the lowest diagnostic yield (75).

Table 7. Ischemic Infarction Diagnostic Testing

Laboratory studies
	• Complete blood count • Erythrocyte sedimentation rate • Chemistry profile • Fasting glucose, hemoglobin A1C level • Prothrombin time, activate partial thromboplastin time, platelets • Toxicology • Rapid plasma reagin/venereal disease research laboratory • Fasting lipid profile • Sickle cell prep • Blood cultures • Pregnancy test
Brain imaging
	• Head CT without contrast • Head MRI without gadolinium • High-resolution (3T) contrast enhanced T1-weighted MRI
Vascular imaging
	• Carotid duplex ultrasound • Trans/cranial Doppler sonography • MRA/CTA of head and neck • Cerebral angiography • Lower extremity ultrasound, pelvic CT or MR venography (in patients with patent foramen ovale)
Cardiac studies
	• ECG • Transesophageal echocardiogram with bubble • Holter
Hypercoagulable screen
	• Protein C activity and free protein S antigen • Antithrombin III • Activated protein C resistance • Factor V Leiden mutation • Russell viper venom time or other screen for lupus anticoagulant and antiphospholipid antibodies (IgG & IgM)/beta2-glycoprotein I antibody • Thrombin time • Fibrinogen • Prothrombin gene 20210A mutation • MTHFR C677T • PAI-1
Other
	• CSF analysis (if vasculitis or infection suspected) • HIV serology • ANA • Lactic acid • Homocysteine • ESR • CRP • Cryoglobulin level • Complement levels • ANCA • Neutrophil cytoplasm antibody (cANCA and pANCA) • Scl-70 antibody • Anti-centromere antibody • Anti-Ro (SSA) and anti-La (SSB) • Serum angiotensin-converting enzyme • Antiproteinase 3 • Lipoprotein (A) • Brain and meningeal biopsy (suspected vasculitis) • Skin biopsy • Sural nerve biopsy • Muscle biopsy
Adapted from (178; 172).

Management

So far, no evidence-based management guideline for stroke in young adults is available. In general terms, treatment in the acute phase of ischemic stroke is similar in both young and older patients (172). Even so, management should be individualized to the patient's diagnosis. Although the causes of stroke in children differ substantially from that in the adults, the vascular distributions and manifestations of stroke are similar in both groups. General supportive care is an appropriate primary step in treatment. Specific therapy directed at minimizing or treating the offending etiology should be pursued (130). In patients with sickle cell disease between the age of 2 and 16 years, periodic transfusion is recommended in patients with abnormal transcranial Doppler study (03; 152). Thrombolytic, surgical, antiplatelet, and anticoagulation recommendations are not different from those of most other age groups (152). To date, thrombolysis is approved for ischemic stroke in patients over 18 years of age. An ongoing trial of thrombolysis in children and adolescents may provide data about the safety and efficacy of thrombolysis in this age group. However, most stroke physicians support the use of intravenous tissue plasminogen activator in carotid dissection and other uncommon etiologies of stroke in young adults (196).

Intravenous alteplase within 4.5 hours of stroke onset was found to be safer and more effective in around 3,250 young stroke patients (18 to 50 years old, median age of 45, median NIHSS score of 10) than in stroke patients 51 to 80 years old (median age of 70, median NIHSS score of 12). The subsets of other and undetermined stroke etiologies according to TOAST criteria were more frequent in young patients than in their older counterparts. Young patients had a better outcome at 3 months (52% with no or minimal disability and 72% with functional independence) than did older patients. Furthermore, symptomatic intracerebral hemorrhage and mortality were lower in younger patients compared to patients over 50 years of age (185). Intravenous thrombolysis was safe and equally effective in patients aged 18 to 50 years with a cerebral infarct and in ischemic stroke patients aged more than 50 years, according to the results of a retrospective observational study based on a large hospital-based stroke registry (151). In this study, 8% of the patients were younger than 50 years of age; a favorable outcome after intravenous thrombolysis (modified Rankin score 1 lower or not worse than pre-stroke mRS) was similar among patients aged 18 to 50 years (OR 1.4) and those aged 51 to 80 years (OR 1.33); patients from 18 to 30 years of age showed the highest benefit from intravenous thrombolysis (OR 2.78). Overall mortality was no different in either group (OR 0.93); nevertheless, in-hospital mortality was lower in patients younger than 50 years of age.

Using information from a national stroke database, Dodds and colleagues compared the rate of intravenous alteplase therapy within 4.5 hours after stroke onset and the rate of symptomatic hemorrhage in two age-differentiated groups of patients admitted with acute ischemic stroke (patients from 18 to 40 years of age and older patients) to 193 hospitals included in the Get with the Guidelines–Stroke Registry (51). In the younger group (30,338 patients), median age was 35 years, 51% were female, half were Caucasian, and one third were African American. In this group, whose median NIHSS score at presentation was three points, the most common stroke risk factors were arterial hypertension (39%), current tobacco use (32%), previous stroke or transient ischemic attack (19%), and diabetes mellitus (18%); risk factor frequency was lower compared with that of the older patients. Compared with patients over 40, this group had higher rates of intravenous thrombolysis (12.8% vs. 8.8%), lower post intravenous thrombolysis complication rates (4.7% vs. 8.6%), and lower symptomatic intracranial hemorrhage rates (1.7% vs. 4.5%) (51). Younger patients also had a better functional outcome than those in the older group: at discharge, 69% of younger patients had a modified Rankin score of 0 to 2 versus 41%. Moreover, in-hospital mortality was lower for younger patients (2.0%) than for the older counterpart (4.3%). Comparing the evaluation time and treatment of the two patient groups, this study showed that younger patients were less likely to undergo brain imaging within 25 minutes of arrival (62.5% vs. 71.5%) or to receive intravenous thrombolysis within 60 minutes of arrival (37% vs. 43%). The hospital type (academic vs. nonacademic) was not a factor in these delays (51).

Other therapeutic strategies in hyperacute stroke are being studied. Results of a randomized trial on the intraarterial treatment delivered on top of intravenous thrombolysis in a 6-hour time window in patients with proximal intracranial occlusion in the anterior circulation for the first time proved the efficacy and safety of intraarterial treatment. The studied population included patients from 23 to 96 years of age (mean age 65 years). The interventional arm had better odds for good recovery at 90 days, defined as a modified Rankin scale score of 0 to 2 (OR 1.66; 95% CI: 1.21-2.28). There was no difference in death rates or incidence of any symptomatic intracerebral hemorrhage. There were more ischemic events in other vascular territories though (17).

Special considerations

Pregnancy

Pregnancy and the postpartum period have long been recognized as important risk factors for both ischemic and hemorrhagic strokes, which occur with similar frequency during this period. Pregnancy increases the risk of stroke by 3-fold to 13-fold; causes of stroke during pregnancy are listed in Table 8 (45). An important study by James and colleagues reported the incidence of pregnancy-related stroke to be 34.2 per 100,000 deliveries, and the mortality rate to be 1.4 per 100,000 deliveries (74). Factors associated with a higher risk for stroke included older age (older than 35 years), African-American race, history of migraine (O.R. 16.9), thrombophilia (O.R. 16.0), SLE (O.R. 15.2), heart disease (O.R. 13.2), sickle cell disease (O.R. 9.1), hypertension (O.R. 6.1), and thrombocytopenia (O.R. 6.0). A higher risk for stroke was found with pregnancy-related complications such as postpartum hemorrhage, preeclampsia, gestational hypertension, need for blood transfusion, postpartum infection, and placental abruption with disseminated intravascular coagulation.

The risk for pregnancy-related stroke is highest in the postpartum period (up to 6 weeks postpartum). Kittner and colleagues found the relative risk for ischemic stroke to be 0.7 during pregnancy; this increased to 8.7 during the postpartum period. The relative risk was found to be 2.5 for intracerebral hemorrhage (exclusive of subarachnoid hemorrhage) but dramatically increased to 28.3 for the postpartum period (81). Most arterial strokes occurred in the third trimester and puerperium, whereas all but one venous infarct occurred in the puerperium (73). In addition to cerebral venous thrombosis, postpartum angiopathy is an important cause for headache in the postpartum period (170; 63; 171). Therefore, postpartum patients with headache or focal deficits should be evaluated with CT angiography with venography.

The results of 151 pregnancy-related strokes were reported in a retrospective analysis to evaluate data on stroke during pregnancy, delivery, and puerperium collected over a 2-year period (2012 and 2013) in 736 teaching hospitals in Japan (206). Interestingly, a higher proportion of hemorrhagic stroke occurred in this study than that reported in Western countries. Out of 111 patients, 73% suffered hemorrhagic stroke, 37 women (25%) had an ischemic stroke, and the remainder had a mixed type of stroke (hemorrhage and infarct simultaneously). The mean age of the 111 patients with hemorrhagic stroke was 32 years, and half of the hemorrhages occurred during pregnancy (mean gestational age: 25 weeks); 14% of hemorrhages occurred at delivery (mean delivery weeks: 38.9), and 25% occurred during puerperium (most after 24 hours postpartum). The four leading etiologies of hemorrhagic stroke were aneurysm (20%), arteriovenous malformation (19%), pregnancy-induced hypertension (12%), and HELPP syndrome (8%). The cause could not be determined in 16% of patients with hemorrhagic stroke. At discharge, 40% of patients exhibited a modified Rankin scale of at least 3. The in-hospital mortality rate was 11%; poor functional outcome was higher in patients with HELLP syndrome (66%) and pregnancy-induced hypertension (46%), whereas just one third of patients with aneurysms and arteriovenous malformation had a poor functional prognosis (206).

The mean age of the 37 patients with ischemic stroke was 30 years; stroke presentation for 50% of these cases was during pregnancy (mean gestational age: 21 weeks), whereas one third (11 patients) developed ischemic strokes during puerperium (most after 24 hours postpartum), and the remaining four cases occurred at delivery (mean delivery weeks: 31.5). Reversible vasoconstriction syndrome was the etiology in approximately 25% of ischemic strokes (nine patients), and coagulopathy was the etiology in 16% (six patients). Cardiogenic embolism, small-vessel disease, and large-artery atherothrombotic disease each accounted for 5% of ischemic strokes and nine patients (24%) had a venous infarction. The etiology remained undetermined in 11% of patients. The in-hospital mortality rate was 2.7%, and 83% of surviving patients had a good clinical outcome (206).

In 240 women of Hispanic origin with cerebrovascular complications occurring during pregnancy and in the first 5 weeks after delivery, 56% developed cerebral venous thrombosis (mean age of 23), 27% had cerebral infarction (mean age of 26), and 16% suffered an intracerebral hemorrhage (mean age of 29) (31). Cerebral venous thrombosis and cerebral hemorrhage peaked during the first and third trimester of pregnancy, respectively, and cerebral infarcts also occurred most frequently in the first and third trimester. Preeclampsia and eclampsia were noted in around one half and one third of cerebral hemorrhages and infarcts, respectively, whereas frequencies were lower in cerebral venous thrombosis. Outcome was favorable in over one half of the women with cerebral venous thrombosis and cerebral infarction, but in only one third of the women with intracerebral hemorrhage.

In a retrospective study of 24 women with a previous ischemic stroke (20 of which were of arterial origin), no recurrence of cerebral infarct was found during pregnancy and puerperium, although one woman had a transient ischemic attack at the 35th week of gestation. The main etiologies of previous ischemic stroke were hypercoagulable state (41%) and cardioembolism (17%); etiology remained unknown in approximately 40% of these strokes. All the women received prophylactic treatment (antiplatelet therapy, low molecular weighted heparin, or both) at the time of index pregnancy and puerperium. The mean interval between previous stroke and index pregnancy was 6.2 years (44).

Based on data from the American Heart Association and American Stroke Association’s Get with the Guidelines Stroke Registry (GWTG-Stroke), 24,641 female patients aged 18 to 44 years were identified with a cerebral infarct from 2008 to 2013; 338 of these patients (1.3%) had a stroke during pregnancy or the postpartum period (45% antepartum, 52% postpartum, and the remainder during delivery). Compared with their nonpregnant counterparts, the pregnant and postpartum patients were younger and did not have the traditional stroke risk factors. Pregnant and postpartum stroke patients had more severe strokes compared with nonpregnant patients, with median NIHSS scores of 13 and 9, respectively. There was no difference in acute stroke reperfusion therapy between the two groups. Symptomatic intracranial hemorrhage associated with intravenous thrombolysis was higher in pregnant and postpartum patients than in nonpregnant patients, with rates of 7.5% versus 2.6%, respectively. Despite this higher rate of intracranial hemorrhages, there was no difference in short-term outcome discharges (in-hospital mortality, discharge to home, or independent ambulation at discharge) between the two groups (95).

The risk of hemorrhagic stroke during pregnancy and postpartum was assessed in a retrospective review of 311 Chinese women with a sporadic brain arteriovenous malformation (BAVM) and at least one related cerebral hemorrhage (101). Brain arteriovenous malformation was confirmed by angiography (CT or digital subtraction angiography) or by histopathological examination. All the patients in this cohort were categorized into four scenarios according to a case-crossover study design; 186 patients were at reproductive age (15 to 45 years), and 106 of them had had at least one gestation. The female patients at reproductive age with at least one previous gestation had a 2.72-fold higher relative risk of hemorrhagic stroke during pregnancy and postpartum, whereas the relative risk was 1.6-fold for female patients at reproductive age with no prior pregnancies (101).

Table 8. Etiologies of Stroke in Pregnancy

Ischemic

Hemorrhagic

• Thromboembolic occlusive disease

• Cardioembolic
- Peripartum cardiomyopathy
- Mitral valve prolapsed
- Prosthetic heart valves
- Atrial fibrillation
- Rheumatic heart disease
- Bacterial endocarditis
- Nonbacterial (marantic) endocarditis
- Paradoxical embolism

• Rare embolic etiologies
- Amniotic fluid
- Air

• Arterial hypotension
- Border-zone infarction
- Sheehan syndrome

• Hematologic disorders
- Disseminated intravascular coagulation
- Thrombotic thrombocytopenic purpura
- Sickle cell disease

• Arteriopathies and arteritis
- Fibromuscular dysplasia
- Systemic lupus erythematosus
- “Isolated” cerebral angiitis

• dAVF

• Cerebral venous sinus thrombosis
- Hypercoagulable state
- Infectious
- Cryptogenic

• Intraparenchymal hemorrhage
- Eclampsia
- Hypertension (other causes)
- Cerebral venous sinus thrombosis
- Arteriovenous malformation
- Vasculitis
- Choriocarcinoma

• Subarachnoid hemorrhage
- Aneurysm
Saccular
Mycotic
- AVM
- dAVF
Cerebral
Spinal cord
- Vasculitis
- Eclampsia
- Cerebral venous thrombosis
- Placental abruption with disseminated intravascular coagulation
- Choriocarcinoma

Adapted from (45).

Anesthesia

Anesthesia issues must be individualized according to the pathophysiology of the patient's stroke. Individuals at risk for increased intracranial pressure should be identified and managed accordingly.

Media

References

01: Aarnio K, Haapaniemi E, Melkas S, Kaste M, Tatlisumak T, Putaala J. Long-term mortality after first-ever and recurrent stroke in young adults. Stroke 2014;45(9):2670-6. PMID 25061076
02: Adams HP Jr, Butler MJ, Biller J, Toffol GJ. Nonhemorrhagic cerebral infarction in young adults. Arch Neurol 1986;43:793-6. PMID 3729759
03: Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998a;339:5-11. PMID 9647873
04: Adams RJ, McKie VC, Brambilla D, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials 1998b;19:110-29. PMID 9492971
05: Al Rajeh S, Awada A. Stroke in Saudi Arabia. Cerebrovasc Dis 2002;13(1):3-8. PMID 11810003
06: Amlie-Lefond C, Bernard TJ, Sébire G, et al. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Circulation 2009;119:1417-23. PMID 19255344
07: Annie F, Bates MC, Nanjundappa A, Bhatt DL, Alkhouli M. Prevalence and outcomes of acute ischemic stroke among patients ≤50 years of age with laboratory confirmed COVID-19 infection. Am J Cardiol 2020;130:169-70. PMID 32690214
08: Anzini A, Cassone A, Rasura M, et al. Chlamydia pneumoniae infection in young stroke patients: a case--control study. Eur J Neurol 2004;11:321-7. PMID 15142225
09: Arboix A, Massons J, Garcia-Eroles L, Oliveres M, Balcells M, Targa C. Migrainous cerebral infarction in the Sagrat Cor Hospital of Barcelona stroke registry. Cephalalgia 2003;23(5):389-94. PMID 12780770
10: Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019;140(11):e596-646.** PMID 30879355
11: Arntz R, Rutten-Jacobs L, Maaijwee N, et al. Post-stroke epilepsy in young adults: a long-term follow-up study. Plos One 2013;8(2):e55498. PMID 23390537
12: Arntz RM, van Alebeek ME, Synhaeve NE, et al. The very long-term risk and predictors of recurrent ischaemic events after a stroke at a young age: the FUTURE study. Eur Stroke J 2016;1(4):337-45. PMID 31008296
13: Arquizan C, Touze E, Moulin T, Woimant F, Ducrocg X, Mas JL. Blood pressure, smoking and oral contraceptive control after cryptogenic stroke in young adults in the PFO-ASA Study. Cerebrovasc Dis 2005;20:41-5. PMID 15942173
14: Awada A, Russell N, al Rajeh S, Omojola M. Non-traumatic cerebral hemorrhage in Saudi-Arabia: a hospital-based study of 243 cases. J Neurol Sci 1996;144(1-2):198-203. PMID 8994124
15: Baig AM, Sanders EC. Potential neuroinvasive pathways of SARS-CoV-2: deciphering the spectrum of neurological deficit seen in coronavirus disease-2019 (COVID-19). J Med Virol 2020;10.1002/jmv.26105. PMID 32492193
16: Benger M, Williams O, Siddiqui J, Sztriha L. Intracerebral haemorrhage and COVID-19: clinical characteristics from a case series. Brain Behav Immun 2020;88:940-44. PMID 32525049
17: Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372(1):11-20. PMID 25517348
18: Biller J, Adams HP Jr, Bruno A, et al. Mortality in acute cerebral infarction in young adults: a ten-year experience. Angiology 1991;42:224-30. PMID 2018244
19: Biller J, Schneck MJ, Love BB. Cardiac disorders and stroke in children and young adults. In: Biller J, editor. Stroke in Children and Young Adults. 2nd ed. Saunders, 2009.
20: Blunt SB, Galton C. Cervical carotid or vertebral artery dissection. BMJ 1997;314:243. PMID 25387643
21: Bogousslavsky J, Pierre P. Ischemic stroke in patients under age 45. Neurol Clin 1992;10:113-24.** PMID 1556998
22: Bogousslavsky J, Regli F. Ischemic stroke in adults younger than 30 years of age. Cause and prognosis. Arch Neurol 1987;44:479-82. PMID 3579657
23: Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 1988;19:1083-92. PMID 3413804
24: Bousser MG, Conard J, Kittner S, et al. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia 2000;20:155-6. PMID 10997767
25: Bova IY, Bornstein NM, Korczyn AD. Acute infection as a risk factor for ischemic stroke. Stroke 1996;27:2204-6. PMID 8969781
26: Brandt T, Orberk E, Weber R, et al. Pathogenesis of cervical artery dissections: association with connective tissue abnormalities. Neurology 2001;57:24-30. PMID 11445623
27: Brey RL, Stallworth CL, McGlasson DL, et al. Antiphospholipid antibodies and stroke in young women. Stroke 2002;33:2396-400. PMID 12364727
28: Broderick M, Rosignoli L, Lunagariya A, Nagaraja N. Hypertension is a leading cause of nontraumatic intracerebral hemorrhage in young adults. J Stroke Cerebrovasc Dis 2020;29(5):104719. PMID 32122779
29: Broman J, Aarnio K, But A, et al. Initiation of antidepressants in young adults after ischemic stroke: a registry-based follow-up study. J Neurol 2022;269(2):956-65. PMID 34165628
30: Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 2007;146(1):34-44. PMID 17200220
31: Cantu-Brito C, Arauz A, Aburto Y, Barinagarrementeria F, Ruiz-Sandoval JL, Baizabal-Carvallo JF. Cerebrovascular complications during pregnancy and postpartum: clinical and prognosis observations in 240 Hispanic women. Eur J Neurol 2011;18(6):819-25. PMID 21143339
32: Carolei A, Marini C, Ferranti E, Frontoni M, Prencipe M, Fieschi C. A prospective study of cerebral ischemia in the young. Analysis of pathogenic determinants. The National Research Council Study Group. Stroke 1993;24:362-7. PMID 8446970
33: Case D, Seinfeld J, Kumpe D, et al. Acute posterior multifocal placoid pigment epitheliopathy associated with stroke: a case report and review of the literature. J Stroke Cerebrovasc Dis 2015;24:e295-302. PMID 26277292
34: Cavalcanti DD, Raz E, Shapiro M, et al. Cerebral venous thrombosis associated with COVID-19. AJNR Am J Neuroradiol 2020;41(8):1370-6. PMID 32554424
35: Chan MT, Nadareishvili ZG, Norris JW. Diagnostic strategies in young patients with ischemic stroke in Canada. Can J Neurol Sci 2000;27:120-4. PMID 10830344
36: Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. The World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ 1999;318:13-8. PMID 9872876
37: Chatzikonstantinou A, Wolf ME, Hennerici MG. Ischemic stroke in young adults: classification and risk factors. J Neurol 2012;259:653-9. PMID 21927959
38: Chen CY, Lin PT, Wang YH, et al. Etiology and risk factors of intracranial hemorrhage and ischemic stroke in young adults. J Chin Med Assoc 2021;84(10):930-6. PMID 34380990
39: Chung JW, Lee SR, Choi EK, et al. Cumulative alcohol consumption burden and the risk of stroke in young adults: a nationwide population-based study. Neurology 2023;100(5):e505-e15. PMID 36323515
40: Cohen BA, Hildebrand F, Biller J. Cardioembolic stroke, part I: clinical patterns and associated cardiac conditions. ACC Current J Rev 1993;5:51-2.
41: Cole JW, Pinto AN, Hebel JR, et al. Acquired immunodeficiency syndrome and the risk of stroke. Stroke 2004;35:51-6. PMID 14684782
42: Collins JG. Prevalence of selected chronic conditions: United States 1990-1992. Vital Health Stat 10 1997:1-89. PMID 9046223
43: Cramer SC, Rordorf G, Maki JH, et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 2004;35:46-50. PMID 14657451
44: Crovetto F, Ossola MW, Spadaccini G, Duiella SF, Somigliana E, Fedele L. Ischemic stroke recurrence during pregnancy: a case series and a review of the literature. Arch Gynecol Obstet 2012;286:599-604. PMID 22546951
45: Dafer RM, Biller JB. Stroke and pregnancy. In: Biller J, editor. Stroke in Children and Young Adults. 2nd ed. Saunders, 2009.
46: de Bruijn MA, Synhaeve NE, van Rijsbergen MW, de Leeuw FE, Jansen BP, de Kort PL. Long-term cognitive outcome of ischaemic stroke in young adults. Cerebrovasc Dis 2014;37(5):376-81. PMID 24970603
47: Del Brutto OH, Sanchez J, Campos X, Santos J, Mosquera A. Non-traumatic intracerebral hemorrhage in young adults living in Guayaquil, Ecuador (South America): analysis of 151 patients. Funct Neurol 1999;14:21-8. PMID 10321326
48: Diener HC, Hankey GJ. Primary and secondary prevention of ischemic stroke and cerebral hemorrhage: JACC Focus Seminar. J Am Coll Cardiol 2020;75(15):1804-18. PMID 32299593
49: DiTullio M, Sacco RL, Venketa N, et al. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993;24:1020-4. PMID 8322376
50: Divani AA, Andalib S, Di Napoli M, et al. Coronavirus Disease 2019 and Stroke: clinical manifestations and pathophysiological insights. J Stroke Cerebrovasc Dis 2020;29(8):104941. PMID 32689643
51: Dodds JA, Xian Y, Sheng S, et al. Thrombolysis in young adults with stroke: findings from Get With The Guidelines–Stroke. Neurology 2019;92(24):e2784-92. PMID 31092622
52: Douay X, Lucas C, Caron C, Goudemand J, Leys D. Antithrombin, protein C and protein S levels in 127 consecutive young adults with ischemic stroke. Acta Neurol Scand 1998;98:124-7. PMID 9724011
53: Ekker MS, Verhoeven JI, Schellekens MMI, et al. Risk Factors and Causes of Ischemic Stroke in 1322 Young Adults. Stroke. 2023;54(2):439-47. PMID 36511150
54: Ekker MS, Verhoeven JI, Vaartjes I, Jolink WMT, Klijn CJM, de Leeuw FE. Association of stroke among adults aged 18 to 49 years with long-term mortality. JAMA 2019;321(21):2113-23. PMID 31121602
55: Frazee JG, Cahan LD, Winter J. Bacterial intracranial aneurysms. J Neurosurg 1980;53:633-41. PMID 6893602
56: Fumal A, Vandenheede M, Coppola G, et al. The syndrome of transient headache with neurological deficits and CSF lymphocytosis (HaNDL): electrophysiological findings suggesting a migrainous pathophysiology. Cephalalgia 2005;25:754-8. PMID 16109060
57: Furie DM, Tien RD. Fibromuscular dysplasia of arteries of the head and neck: imaging findings. Am J Roentgenol 1994;162(5):1205-9. PMID 8166011
58: Gedansky A, Jarvis P, Yu D, Lu X, Heiman-Patterson T, Linares G. Intracerebral hemorrhage in a young urban population: etiologies and outcomes in patients 50 and younger. J Stroke Cerebrovasc Dis 2019;28(10):104295. PMID 31375404
59: Ghandehari K, Moud ZI. Incidence and etiology of ischemic stroke in Persian young adults. Acta Neurol Scand 2006;113(2):121-4. PMID 16411973
60: Giang KW, Björck L, Ståhl CH., et al. Trends in risk of recurrence after the first ischemic stroke in adults younger than 55 years of age in Sweden. Int J Stroke 2016,11:52-61. PMID 26763020
61: Gilon D, Buonanno FS, Joffe MM, et al. Lack of evidence of an association between mitral-valve prolapse and stroke in young patients. N Engl J Med 1999;341:8-13. PMID 10387936
62: Giroud M, Lemesle M, Gouyon JB, Nivelon JL, Milan C, Dumas R. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol 1995;481343-8. PMID 7490597
63: Gladstone JP, Dodick DW, Evans R. The young woman with postpartum “thunderclap” headache. Headache 2005;45:70-4. PMID 15663616
64: Greaves M. Coagulation abnormalities and cerebral infarction. J Neurol Neurosurg Psychiatry 1993;56:433-9. PMID 8505629
65: Griffin KJ, Harmsen WS, Mandrekar J, Brown RD Jr, Keser Z. Epidemiology of Spontaneous Cervical Artery Dissection: Population-Based Study. Stroke 2024;55(3):670-7. PMID 38288608
66: Groppo E, De Gennaro R, Granieri G, et al. Incidence and prognosis of stroke in young adults: a population-based study in Ferrara, Italy. Neurol Sci 2012;33:53-8. PMID 21695657
67: Gunel M, Awad IA, Finberg K, et al. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med 1996;334:946-51. PMID 8596595
68: Hart RG, Easton JD. Dissections. Stroke 1985;16:925-7. PMID 3911505
69: Hart RG, Miller VT. Cerebral infarction in young adults: a practical approach. Stroke 1983;14:110-4. PMID 6337424
70: Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders: 3rd edition. Cephalalgia 2013;33(9):629-808. PMID 23771276
71: Jacobs BS, Boden-Albala B, Lin IF, Sacco RL. Stroke in the young in the northern Manhattan stroke study. Stroke 2002;33:2789-93. PMID 12468771
72: Jaffre A, Ruidavets JB, Calviere L, Viguier A, Ferrieres J, Larrue V. Risk factor profile by etiological subtype of ischemic stroke in the young. Clin Neurol Neurosurg 2014;120:78-83. PMID 24731581
73: Jaigobin C, Silver FL. Stroke and pregnancy. Stroke 2000;31:2948-51. PMID 11108754
74: James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005;104:509-16. PMID 16135580
75: Ji R, Schwamm LH, Pervez MA, Singhal AB. Ischemic stroke and transient ischemic attack in young adults: risk factors, diagnostic yield, neuroimaging, and thrombolysis. Arch Neurol 2012:1-7. PMID 23108720
76: Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-10. PMID 8878478
77: Kappelle LJ, Adams HP, Jr., Heffner ML, Torner JC, Gomez F, Biller J. Prognosis of young adults with ischemic stroke: a long-term follow-up study assessing recurrent vascular events and functional outcome in the Iowa Registry of Stroke in Young Adults. Stroke 1994;25:1360-5. PMID 8023350
78: Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 2000;343:1826-32. PMID 11117973
79: Kittner SJ. Stroke in young adults: progress and opportunities. Neuroepidemiology 1998;17:174-8. PMID 9701831
80: Kittner SJ, McCarter RJ, Sherwin RW, et al. Black-white differences in stroke risk among young adults. Stroke 1993;24:I13-15; discussion I20-11. PMID 8249010
81: Kittner SJ, Stern BJ, Feeser BR, et al. Pregnancy and the risk of stroke. N Engl J Med 1996;335:768-74. PMID 8703181
82: Kittner SJ, Stern BJ, Wozniak M, et al. Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998;50:890-4. PMID 9566368
83: Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke 2021;52(7):e364-467.** PMID 34024117
84: Kloss M, Grond-Ginsbach C, Ringleb P, Hausser I, Hacke W, Brandt T. Recurrence of cervical artery dissection: an underestimated risk. Neurology 2018;90(16):e1372-8.** PMID 29549224
85: Kodama N, Fujiwara S, Horie Y, et al. Transdural anastomosis in Moyamoya disease: Vault Moyamoya. Neurol Surg 1980;8:729-37. PMID 7422063
86: Koivunen RJ, Satopaa J, Haapaniemi E, et al. Predictors of early mortality in young adults after intracerebral hemorrhage. Stroke 2014;45(8):2454-6. PMID 24947290
87: Koivunen RJ, Satopaa J, Meretoja A, et al. Incidence, risk factors, etiology, severity and short-term outcome of non-traumatic intracerebral hemorrhage in young adults. Eur J Neurol 2015;22(1):123-32.** PMID 25142530
88: Kolodny E, Fellgiebel A, Hilz MJ, et al. Cerebrovascular involvement in Fabry disease: current status of knowledge. Stroke 2015;46(1):302-13. PMID 25492902
89: Kono Y, Terasawa Y, Sakai K, et al. Risk factors, etiology, and outcome of ischemic stroke in young adults: a Japanese multicenter prospective study. J Neurol Sci 2020;417:117068. PMID 32745720
90: Kristensen B, Malm J, Carlberg B, et al. Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke 1997;28:1702-9. PMID 9303012
91: Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol 2008;7:1056-66. PMID 18940695
92: Lai SL, Chen ST, Lee TH, Ro LS, Hsu SP. Spontaneous intracerebral hemorrhage in young adults. Eur J Neurol 2005;12(4):310-6. PMID 15804249
93: Leblanc R. Familial cerebral aneurysms. A bias for women. Stroke 1996;27:1050-4. PMID 8650713
94: Lee VH, Brown RD Jr, Mandrekar JN, Mokri B. Incidence and outcome of cervical artery dissection: a population-based study. Neurology 2006;67(10):1809-12. PMID 17130413
95: Leffert LR, Clancy CR, Bateman BT, et al. Treatment patterns and short-term outcome in ischemic stroke in pregnancy or postpartum period. Am J Obstet Gynecol 2016;214(6):723.e1-723.e11 PMID 26709084
96: Leppert MH, Ho PM, Burke J, et al. Young women had more strokes than young men in a large, United States claims sample. Stroke 2020;51(11):3352-5. PMID 32942966
97: Leys D, Bandu L, Henon H, et al. Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke. Neurology 2002;59:26-33.** PMID 12105303
98: Li F, Yang L, Yang R, et al. Ischemic stroke in young adults of northern China: characteristics and risk factors for recurrence. Eur Neurol 2017;77(3-4):115-22. PMID 28052272
99: Li X, Wang Y, Chen W, et al. Intracerebral hemorrhage due to developmental venous anomalies. J Clin Neurosci 2016;26:95-100. PMID 26803466
100: Liu A, Pirastehfar M, Yu D, Linares G. Phenotypic ASCOD characterisations of ischaemic stroke in the young at an urban tertiary care centre. Stroke Vasc Neurol 2018;3(4):209-14. PMID 30637126
101: Liu J, Zhang H, Luo C, et al. Haemorrhage risk of brain arteriovenous malformation during pregnancy and puerperium. Stroke Vasc Neurol 2023;8(4):307-17. PMID 36599484
102: Love BB, Biller JB. Stroke in children and young adults: overview, risk factors, and prognosis. In: Biller J, editor. Stroke in Children and Young Adults. 2nd ed. Saunders, 2009.
103: Macko RF, Ameriso SF, Barndt R, Clough W, Weiner JM, Fisher M. Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke 1996;27:1999-2004. PMID 8898805
104: Madre JG, Garcia JL, Gonzalez RC, et al. Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke. Eur J Neurol 2002;9:303-6. PMID 11985640
105: Malarcher AM, Giles WH, Croft JB, et al. Alcohol intake, type of beverage, and the risk of cerebral infarction in young women. Stroke 2001;32:77-83. PMID 11136918
106: Maljaars J, Garg A, Molian V, Leira EC, Adams HP, Shaban A. The intracerebral hemorrhage score overestimates mortality in young adults. J Stroke Cerebrovasc Dis 2021;30(9):105963. PMID 34247055
107: Margaglione M, D'Andrea G, Giuliani N, et al. Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol 1999;19:1751-6. PMID 10397694
108: Marini C, Totaro R, De Santis F, Ciancarelli I, Baldassarre M, Carolei A. Stroke in young adults in the community-based L'Aquila registry: incidence and prognosis. Stroke 2001;32:52-6. PMID 11136914
109: Markus HS, Martin RJ, Simpson MA, et al. Diagnostic strategies in CADASIL. Neurology 2002;59:1134-8. PMID 12395806
110: Martin PJ, Enevoldson TP, Humphrey PR. Causes of ischaemic stroke in the young. Postgrad Med J 1997;73:8-16. PMID 9039403
111: Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998;338:1793-7. PMID 9632445
112: Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-6. PMID 11742048
113: McKenna MC, Fanning N, Cronin S. Focal cerebral arteriopathy in young adult patients with stroke. Stroke 2020;51(5):1596-9. PMID 32212896
114: Mehndiratta MM, Agarwal P, Sen K, Sharma B. Stroke in young adults: a study from a university hospital in north India. Med Sci Monit 2004;10:CR535-41. PMID 15328488
115: Mehndiratta P, Ryan KA, Cronin C, et al. Differences in multiple risk factors between black and white individuals with young-onset ischemic stroke. Neurology 2022;99(6):e560-e4. PMID 35613933
116: Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45(12):3754-832.** PMID 25355838
117: Messé SR, Gronseth GS, Kent DM, et al. Practice advisory update summary: patent foramen ovale and secondary stroke prevention: report of the Guideline Subcommittee of the American Academy of Neurology. Neurology 2020;94(20):876-85.** PMID 32350058
118: Metso TM, Tatlisumak T, Debette S, et al. Migraine in cervical artery dissection and ischemic stroke patients. Neurology 2012;78:1221-8. PMID 22491867
119: Mettinger KL, Ericson K. Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. Stroke 1982;13:46-52. PMID 7064180
120: Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course. AJNR Am J Neuroradiol 2015;36(8):1392-9. PMID 25593203
121: Mocellin R, Walterfang M, Velakoulis D. Hashimoto's encephalopathy: epidemiology, pathogenesis and management. CNS Drugs 2007;21:799-811. PMID 17850170
122: Mokri B, Houser OW, Sandok BA, Piepgras DG. Spontaneous dissections of the vertebral arteries. Neurology 1988;38:880-5. PMID 3368069
123: Mokri B, Sundt TM Jr, Houser OW, Piepgras DG. Spontaneous dissection of the cervical internal carotid artery. Ann Neurol 1986;19:126-38. PMID 3963755
124: Musolino R, La Spina P, Granata A, et al. Ischaemic stroke in young people: a prospective and long-term follow-up study. Cerebrovasc Dis 2003;15:121-8. PMID 12499721
125: Nachman RL, Silverstein R. Hypercoagulable states. Ann Intern Med 1993;119:819-27. PMID 8379603
126: Naess H, Waje-Andreassen U, Thomassen L, Nyland H, Myhr KM. Do all young ischemic stroke patients need long-term secondary preventive medication. Neurology 2005;65(4):609-11. PMID 16116127
127: Nakagawa E, Hoffmann M. Young women’s stroke etiology differs from that in young men: an analysis of 511 patients. Neurol Int 2013;5(3):e12. PMID 24147209
128: Neau JP, Ingrand P, Mouille-Brachet C, et al. Functional recovery and social outcome after cerebral infarction in young adults. Cerebrovasc Dis 1998;8:296-302. PMID 9712928
129: Nedeltchev K, der Maur TA, Georgiadis D, et al. Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry 2005;76:191-5. PMID 15654030
130: Ning M, Furie KL. Preventing a second stroke in the young. Top Stroke Rehabil 2004;11:40-50. PMID 15118966
131: Niu JW, Gao S, Cui LY, et al. Intracranial atherosclerosis in Chinese young adult stroke patients. J Stroke Cerebrovasc Dis 2014;23(6):1519-23. PMID 24582785
132: Niu X, Ou‑Yang G, Yan PF, Huang SL, Zhang ZT, Zhang ZH. Closure of patent foramen ovale for cryptogenic stroke patients: an updated systematic review and meta‑analysis of randomized trials. J Neurol 2018;265(6):1259-68. PMID 29383514
133: North KN, Whiteman DA, Pepin MG, Byers PH. Cerebrovascular complications in Ehlers-Danlos syndrome type IV. Ann Neurol 1995;38:960-4. PMID 8526472
134: Nuñez M, Delfino C, Asenjo-Lobos C, et al. Disparities in stroke incidence over time by sex and age in Latin America and the Caribbean Region 1997 to 2021: a systematic review and meta-analysis. J Am Heart Assoc 2023;12(17):e029800. PMID 37642019
135: Oxley TJ, Mocco J, Majidi S, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020;382(20):e60. PMID 32343504
136: Patella R, Spalloni A, Ferrari M, La Starza S, Bozzao A, Rasura M. Cerebral ischemia in young patients (under 45 years of age): clinical and neuroradiological follow-up. Neurol Sci 2011;32(3):427-32. PMID 21365292
137: Peng KP, Chen YT, Fuh JL, Tang CH, Wang SJ. Migraine and incidence of ischemic stroke: a nationwide population-based study. Cephalalgia 2016;pii:0333102416642602. PMID 27118220
138: Pezzini A, Grassi M, Lodigiani C, et al; Italian Project on Stroke in Young Adults Investigators. Predictors of migraine subtypes in young adults with ischemic stroke: the italian project on stroke in young adults. Stroke 2011;42(1):17-21. PMID 21106957
139: Pezzini A, Grassi M, Lodigiani C, et al; Italian Project on Stroke in Young Adults Investigators. Predictors of long-term recurrent vascular events after ischemic stroke at young age: the Italian Project on Stroke in Young Adults. Circulation 2014;129(16):1668-76. PMID 24508827
140: Piechowski-Jozwiak B, Bogousslavsky J. Cervicocephalic fibromuscular dysplasia. In: Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA, editors. Stroke pathophysiology, diagnosis, and management. 4th edition. Elsevier, 2004:619-28.
141: Piechowski-Jozwiak B, Bogousslavsky J. Stroke and patent foramen ovale in young individuals. Eur Neurol 2013;69(2):108-17. PMID 23207510
142: Pinto AN. AIDS and cerebrovascular disease. Stroke 1996;27(3):538-43. PMID 8610326
143: Prefasi D, Martínez-Sánchez P, Rodríguez-Sanz A, et al. Atrial fibrillation in young stroke patients: do we underestimate its prevalence. Eur J Neurol 2013;20(10):1367-74. PMID 23678962
144: Putaala J, Metso AJ, Metso TM, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first ever ischemic stroke: the Helsinki young stroke registry. Stroke 2009;40:1195-203.** PMID 19246709
145: Putaala J, Strbian D, Mustanoja S, Haapaniemi E, Kaste M, Tatlisumak T. Functional outcome in young adult ischemic stroke: impact of lipoproteins. Acta Neurol Scand 2013;127(1):61-9. PMID 22616937
146: Qureshi AI, Janssen RS, Karon JM, et al. Human immunodeficiency virus infection and stroke in young patients. Arch Neurol 1997;54:1150-3. PMID 9311359
147: Radhakrishnan K, Ashok PP, Sridharan R, Mousa ME. Stroke in the young: incidence and pattern in Benghazi, Libya. Acta Neurol Scand 1986;73(4):434-8. PMID 3727919
148: Rasmussen LD, Engsig FN, Christensen H, et al. Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study. AIDS 2011;25(13):1637-46. PMID 21646903
149: Rasura M, Spalloni A, Ferrari M, et al. A case series of young stroke in Rome. Eur J Neurol 2006;13(2):146-52. PMID 16490045
150: Razzaq AA, Khan BA, Baig SM. Ischemic stroke in young adults of South Asia. J Pak Med Assoc 2002;52:417-22. PMID 12532578
151: Reuter B, Gumbinger C, Sauer T, et al. Intravenous thrombolysis is effective in young adults: results from the Baden- Wuerttemberg Stroke Registry. Front Neurol 2015;2015;6:229. PMID 26581808
152: Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008;39(9):2644-91. PMID 18635845
153: Rohr J, Kittner S, Feeser B, et al. Traditional risk factors and ischemic stroke in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Arch Neurol 1996;53:603-7. PMID 8929167
154: Roivainen R, Haapaniemi E, Putaala J, Kaste M, Tatlisumak T. Young adult ischaemic stroke related acute symptomatic and late seizures: risk factors. Eur J Neurol 2013;20(9):1247-55. PMID 23581284
155: Rolfs A, Fazekas F, Grittner U, et al. Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study. Stroke 2013;44(2):340-9. PMID 23306324
156: Rubinstein SM, Peerdeman SM, van Tulder MW, Riphagen I, Haldeman S. A systematic review of the risk factors for cervical artery dissection. Stroke 2005;36:1575-80. PMID 15933263
157: Ruiz-Sandoval JL, Cantu C, Barinagarrementeria F. Intracerebral hemorrhage in young people: analysis of risk factors, location, causes, and prognosis. Stroke 1999;30:537-41. PMID 10066848
158: Rumalla K, Reddy AY, Mittal MJ. Recreational marijuana use and acute ischemic stroke: a population-based analysis of hospitalized patients in the United States. J Neurol Sci 2016;364:191-6. PMID 26874461
159: Rutten-Jacobs LC, Maaijwee NA, Arnstz RM, et al. Long-term risk of recurrent vascular events after young stroke: the FUTURE Study. Ann Neurol 2013;74(4):592-601. PMID 23776015
160: Sanak D, Hutyra M, Kral M, et al. Atrial fibrillation in young ischemic stroke patients: an underestimated cause? Eur Neurol 2015;73(3-4):158-63. PMID 25573455
161: Saric M, Armour AC, Arnaout S, et al. Guidelines for the use of the echocardiography in the evaluation of a cardiac source of embolism. J Am Soc Echocardiogr 2016;29:1-42. PMID 26765302
162: Schaapsmeerders P, Maaijwee NA, van Dijk EJ, et al. Long-term cognitive impairment after first-ever ischemic stroke in young adults. Stroke 2013;44(6):1621-8. PMID 23652272
163: Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 2001;344:898-906. PMID 11259724
164: Schievink WI. Cerebrovascular Involvement in Ehlers-Danlos Syndrome. Curr Treat Options Cardiovasc Med 2004;6:231-236. PMID 15096315
165: Schwartz NE, Vertinsky AT, Hirsch KG, Albers GW. Clinical and radiographic natural history of cervical artery dissections. J Stroke Cerebrovasc Dis 2009;18(6):416-23. PMID 19900642
166: Sciascia S, Sanna G, Khamashta MA, et al. The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review. Ann Rheum Dis 2015;74(11):2028-33. PMID 24942381
167: Shaban A, Molian V, Garg A, Limaye K, Leira EC, Adams Jr HP. Secular trends for etiologies of acute ischemic stroke in young adults. J Stroke Cerebrovasc Dis 2020;29(12):105270. PMID 32992166
168: Shi Q, Chen J, Pongmoragot J, Lanthier S, Saposnik G. Prevalence of Fabry disease in stroke patients--a systematic review and meta-analysis. J Stroke Cerebrovasc Dis 2014;23(5):985-92. PMID 24126289
169: Singhal AB. Cerebral vasoconstriction syndromes. Top Stroke Rehabil 2004a;11:1-6. PMID 15118961
170: Singhal AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol 2004b;61:411-6. PMID 15023819
171: Singhal AB, Bernstein RA. Postpartum angiopathy and other cerebral vasoconstriction syndromes. Neurocrit Care 2005;3:91-7. PMID 16159105
172: Singhal AB, Biller J, Elkind MS, et al. Recognition and management of stroke in young adults and adolescents. Neurology 2013;81(12):1089-97. PMID 23946297
173: Singhal AB, Caviness VS, Begleiter AF, Mark EJ, Rordorf G, Koroshetz WJ. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 2002;58:130-3. PMID 11781419
174: Singhal AB, Hajj-Ali RA, Topcuoglu MA, et al. Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 2011;68(8):1005-12.** PMID 21482916
175: Spengos K, Vemmos K. Risk factors, etiology, and outcome of first-ever ischemic stroke in young adults aged 15 to 45 – the Athens young stroke registry. Eur J Neurol 2010;17(11):1358:64. PMID 20482604
176: Stang PE, Carson AP, Rose KM, et al. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 2005;64:1573-7. PMID 15883318
177: Stern BJ, Kittner S, Sloan M, et al. Stroke in the young. (Part I). Md Med J 1991;40:453-62. PMID 1861584
178: Stern BJ, Wityk RJ. Stroke in the young. In: Feldmann E, editor. Current Diagnosis in Neurology. St. Louis (MO): Mosby, 1994.
179: Strater R, Becker S, von Eckardstein A, et al. Prospective assessment of risk factors for recurrent stroke during childhood--a 5-year follow-up study. Lancet 2002;360:1540-5. PMID 12443591
180: Suzuki J, Kodama N. Cerebral vascular “Moyamoya” disease. II. Collateral routes to forebrain via ethmoid sinus and superior nasal meatus. Angiology 1971;22:223-36. PMID 5554209
181: Suzuki J, Kodama N. Moyamoya disease--a review. Stroke 1983;14:104-9. PMID 6823678
182: Swor DE, Maas MB, Walia SS, et al. Clinical characteristics and outcomes of methamphetamine-associated intracerebral hemorrhage. Neurology 2019;93(1):e1-7. PMID 31142634
183: Synhaeve NE, Arntz RM, van Alebeek ME, et al. Women have a poorer very long-term functional outcome after stroke among adults aged 18-50 years: the FUTURE study. J Neurol 2016;263(6):1099-105. PMID 27039389
184: Toffol GJ, Biller J, Adams HP Jr. Nontraumatic intracerebral hemorrhage in young adults. Arch Neurol 1987;44:483-5.** PMID 3579658
185: Toni D, Ahmed N, Anzini A, for the SITS Investigators. Intravenous thrombolysis in young stroke patients. Results from the SITS-ISTR. Neurology 2012;78:880-7. PMID 22402853
186: Topcuoglu MA, Palacios IF, Buonanno FS. Contrast M-mode power Doppler ultrasound in the detection of right-to-left shunts: utility of submandibular internal carotid artery recording. J Neuroimaging 2003;13:315-23. PMID 14569823
187: Trivedi MM, Ryan KA, Cole JW. Ethnic differences in ischemic stroke subtypes in young-onset stroke: The Stroke Prevention in Young Adults Study. BMC Neurol 2015;15:221. PMID 26515647
188: Truelsen T, Piechowski-Jóźwiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G. Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol 2006;13(6):581-98. PMID 16796582
189: Tzourio C, Tehindrazanarivelo A, Iglesias S, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995;310:830-3. PMID 7711619
190: van Alebeek ME, Arntz RM, Ekker MS, et al. Risk factors and mechanisms of stroke in young adults: the FUTURE study. J Cereb Blood Flow Metab 2018;38(9):1631-41. PMID 28534705
191: Varona JF, Bermejo F, Guerra JM, Molina JA. Long-term prognosis of ischemic stroke in young adults. Study of 272 cases. J Neurol 2004;251:1507-14. PMID 15645352
192: Verburgt E, Hilkens NA, Ekker MS, et al. Short-term and long-term risk of recurrent vascular event by cause after ischemic stroke in young adults. JAMA Netw Open 2024;7(2):e240054. PMID 38376841
193: Viswanathan A, Chabriat H. Cerebral microhemorrhage. Stroke 2006;37(2):550-5. PMID 16397165
194: Voetsch B, Jin RC, Bierl C, et al. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke 2007;38(1):41-9. PMID 17122425
195: von Sarnowski B, Schminke U, Grittner U, et al. Posterior versus anterior circulation stroke in young adults: a comparative study of stroke aetiologies and risk factors in stroke among young Fabry patients (sifap1). Cerebrovasc Dis 2017;43(3-4):152-60. PMID 28088807
196: Wagner JC, Lutsep HL. Thrombolysis in young adults. J Thromb Thrombolysis 2005;20:133-6. PMID 16205862
197: Waje-Andreassen U, Thomassen L, Jusufovic M, et al. Ischaemic stroke at young age is a serious event – final results of a population-based long term follow-up in Western Norway. Eur J Neurol 2013;20(5):818-23. PMID 23293975
198: Welch KM. Relationship of stroke and migraine. Neurology 1994;44:S33-6. PMID 7969944
199: Westover AN, McBride S, Haley RW, et al. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry 2007;64:495-502. PMID 17404126
200: Wolf ME, Szabo K, Griebe M, et al. Clinical and MRI characteristics of acute migrainous infarction. Neurology 2011;76(22):1911-7. PMID 21624990
201: Wolff V, Armspach JP, Lauer V, et al. Ischaemic strokes with reversible vasoconstriction and without thunderclap headache: a variant of the reversible cerebral vasoconstriction syndrome? Cerebrovasc Dis 2015;39(1):31-8. PMID 25547150
202: Wolff V, Jouanjus E. Strokes are possible complications of cannabinoids use. Epilepsy Behav 2017;70(Pt B):355-63. PMID 28237318
203: Yamashiro Y, Takahashi H, Takahashi K. Cerebrovascular Moyamoya disease. Eur J Pediatr 1984;142:44-50. PMID 6370699
204: Yesilot Barlas N, Putaala J, Waje-Andreassen U, et al. Etiology of first-ever ischaemic stroke in European young adults: the 15 cities young stroke study. Eur J Neurol 2013;20(11):1431-9.** PMID 23837733
205: Yilmaz EY, Pritz MB, Bruno A, et al. Moyamoya: Indiana University Medical Center experience. Arch Neurol 2001;58:1274-8. PMID 11493168
206: Yoshida K, Takahashi JC, Takenobu Y, Suzuki N, Ogawa A, Miyamoto S. Strokes associated with pregnancy and puerperium: a nationwide study by the Japan Stroke Society. Stroke 2017;48(2):276-82. PMID 28028148
207: You RX, McNeil JJ, O'Malley HM, Davis SM, Thrift AG, Donnan GA. Risk factors for stroke due to cerebral infarction in young adults. Stroke 1997;28:1913-8. PMID 9341695
208: Zhang R, Liu H, Pu L, et al. Global burden of ischemic stroke in young adults in 204 countries and territories. Neurology 2023;100(4):e422-e34. PMID 36307222
209: Zunker P, Hohenstein C, Plendl HJ, et al. Activated protein C resistance and acute ischaemic stroke: relation to stroke causation and age. J Neurol 2001;248:701-4. PMID 11569900

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Authors

Julien Bogousslavsky MD

Dr. Bogousslavsky of the Swiss Medical Network has no relevant financial relationships to disclose.
See Profile
Jorge Moncayo-Gaete MD

Dr. Moncayo-Gaete of Universidad Internacional del Ecuador has no relevant financial relationships to disclose.
See Profile

Editor

Steven R Levine MD

Dr. Levine of the SUNY Health Science Center at Brooklyn has no relevant financial relationships to disclose.
See Profile

Former Authors

Barney J Stern MD
Robert Wityk MD
Brett Meyer MD
Justin Zivin MD PhD
Aneesh B Singhal MD
Sandra Narayanan MD
Rima M Dafer MD
Bartlomiej Piechowski-Jozwiak MD

Patient Profile

Age range of presentation: 13 to 44 years
Sex preponderance: male=female
Heredity: heredity may be a factor
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-10: Cerebrovascular diseases: I60-I69

Venous complications in pregnancy: O22

Venous complication in the puerperium, unspecified: O87.9
ICD-11: Cerebrovascular diseases, unspecified: 8B2Z

Venous complications in pregnancy: JA61

Venous complications in the puerperium: JB41
OMIM: Ischemic stroke: #601367

Susceptibility to stroke, 1: %606799

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Stroke in young adults

Differential Diagnosis

acute subdural hematoma
acute vestibular syndrome
atherosclerosis
basilar and hemiplegic migraines
brachial neuritis
- brain metastases
- brain tumor
- carotid and vertebral artery dissection
- central neurologic complications of pregnancy
- cerebral arteriopathies
- cerebral contusions
- cerebral vasoconstriction syndromes
- cervical disc disease
- cerebral embolism
- cerebral venous thrombosis
- complications of parenteral nutrition
- conversion disorder
- diabetic ketoacidosis
- drug-induced cerebrovascular disease
- encephalitis
- epilepsia partialis continua of Kozhevnikov
- Fabry disease
- fibromuscular dysplasia
- focal seizures
- hemiplegic migraine
- hypercoagulable states and cerebrovascular disease
- hyperglycemic hyperosmolar nonketotic state
- hyperhomocysteinemia
- hypoglycemia
- infective endocarditis
- low-grade gliomas (astrocytomas)
- malignant astrocytomas
- MELAS
- methamphetamine-associated intracerebral hemorrhage
- migraine with prolonged aura
- migrainous infarction
- moyamoya disease
- multiple sclerosis
- neurologic complications of chiropractic manipulation
- neuromuscular junction disorders
- neuropathy
- neurovascular trauma
- periodic paralysis
- pilocytic astrocytoma in adults
- pregnancy and stroke
- radial neuropathy
- radiculopathy
- hematologic disease
- oral contraceptives and stroke
- pregnancy and stroke
- Sneddon syndrome
- stroke associated with drug abuse
- stroke associated with sickle cell disease
- subdural hematoma
- Takayasu disease
- vertebral artery dissections
- Wernicke encephalopathy

Also Relevant

Aortic atherosclerosis and stroke
Anterior cerebral artery stroke syndromes
Cerebral arteriopathies
Cerebrovascular complications of cancer
Depression after stroke
- Hemorrhagic transformation of ischemic stroke
- Hormonal contraception and stroke
- Intracranial atherosclerosis
- Ischemic stroke
- Lacunar infarction
- Medical complications of stroke
- Reversible cerebral vasoconstriction syndromes
- Stroke associated with atrial fibrillation
- Stroke associated with cerebral angiography
- Stroke associated with myocardial infarction
- Stroke: supportive care
- Stroke therapy

Stroke in young adults

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Table 1. Selected Historical Information

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Table 2. Conditions Associated with Cardiac Emboli

Table 3. Selected Hematologic Disorders Associated with Stroke

Table 4. Other Conditions Associated with Stroke

Table 5. Selected Causes of Spontaneous Intracranial Hemorrhage

Diagnostic workup

Table 6. Clues from Examination of the Eyes and Skin

Table 7. Ischemic Infarction Diagnostic Testing

Management

Special considerations

Pregnancy

Table 8. Etiologies of Stroke in Pregnancy

Anesthesia

Media

References

Contributors

Authors

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

NF2-related schwannomatosis

Breath-holding spells

Ischemic stroke

Cerebral embolism

Hormonal contraception and stroke

Acute cerebellar ataxia in children

Antiphospholipid antibody syndrome

Headache in children: overview and treatment approaches

This is an article preview.
Start a Free Account
to access the full version.